var title_f22_6_22624="Contents: General medical issues in women";
var content_f22_6_22624=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?6/40/6798\">",
"       Obstetrics, Gynecology and Women's Health",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       General medical issues in women",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			General medical issues in women",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Adolescents",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/35/19000\">",
"           Guidelines for adolescent preventive services",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Breast disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/15/24825\">",
"           Breast masses and other common breast problems",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/33/8728\">",
"           Breast pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/23/3449\">",
"           Nipple discharge",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/52/11081\">",
"           Overview of benign breast disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/49/41754\">",
"           Screening for breast cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cardiovascular disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/9/41113\">",
"           Clinical features and diagnosis of coronary heart disease in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/35/28217\">",
"           Coronary heart disease and myocardial infarction in young men and women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/57/28570\">",
"           Determinants and management of cardiovascular risk in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/63/11258\">",
"           Management of coronary heart disease in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/29/33241\">",
"           Screening guidelines for dyslipidemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Endocrine disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/42/33449\">",
"           Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/52/39751\">",
"           Clinical manifestations and diagnosis of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/6/16490\">",
"           Clinical manifestations of polycystic ovary syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/36/39495\">",
"           Diagnosis of polycystic ovary syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/16/28935\">",
"           Epidemiology and pathogenesis of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/2/2089\">",
"           Etiology, diagnosis, and treatment of primary amenorrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/56/34697\">",
"           Etiology, diagnosis, and treatment of secondary amenorrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/31/9721\">",
"           Evaluation of premenopausal women with hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/63/14329\">",
"           Management of Turner syndrome (gonadal dysgenesis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/28/24007\">",
"           Pathogenesis and causes of hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/2/27685\">",
"           Physiology of the normal menstrual cycle",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/37/35416\">",
"           Treatment of hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/10/3241\">",
"           Treatment of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/59/22455\">",
"           Clinical manifestations and diagnosis of irritable bowel syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/22/13673\">",
"           Etiology and evaluation of chronic constipation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/57/30616\">",
"           Management of chronic constipation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/25/12697\">",
"           Pathophysiology of irritable bowel syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/14/40169\">",
"           Treatment of irritable bowel syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General hematology/oncology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/3/5178\">",
"           Approach to the adult patient with a bleeding diathesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/39/26234\">",
"           Causes and diagnosis of anemia due to iron deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/41/11930\">",
"           Evaluation of the patient with established venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/62/25578\">",
"           Treatment of anemia due to iron deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/53/10072\">",
"           Women and lung cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gynecologic issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/1/24601\">",
"           Approach to the patient with an adnexal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/15/24825\">",
"           Breast masses and other common breast problems",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/15/40185\">",
"           Cervical cytology: Interpretation of results",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/57/19352\">",
"           Differential diagnosis of the adnexal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/11/30905\">",
"           Management of an adnexal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14810\">",
"           Overview of the treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/48/19210\">",
"           Pathogenesis, clinical features, and diagnosis of endometriosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hernia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/37/31321\">",
"           Classification, clinical features and diagnosis of inguinal and femoral hernias in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/20/29000\">",
"           Overview of treatment for inguinal and femoral hernias",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypertension",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/29/36314\">",
"           Choice of therapy in primary (essential) hypertension: Recommendations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/62/37859\">",
"           Effect of oral contraceptives and postmenopausal hormone therapy on blood pressure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/63/3060\">",
"           Essential hypertension in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/4/4169\">",
"           Hypertension: Who should be treated?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/40/33417\">",
"           What is goal blood pressure in the treatment of hypertension?",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neurologic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/44/21194\">",
"           Acute treatment of migraine in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/34/3624\">",
"           Headache syndromes other than migraine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/4/26698\">",
"           Pathophysiology, clinical manifestations, and diagnosis of migraine in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Obesity",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/9/8345\">",
"           Dietary therapy for obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/4/33866\">",
"           Drug therapy of obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/35/30266\">",
"           Health hazards associated with obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/45/13016\">",
"           Overview of therapy for obesity in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Osteoporosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/52/39754\">",
"           Overview of the management of osteoporosis in postmenopausal women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/28/40393\">",
"           Screening for osteoporosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other infectious diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14803\">",
"           Cellulitis following pelvic lymph node dissection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/6/30825\">",
"           Clinical features and diagnosis of chronic fatigue syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/21/4440\">",
"           Treatment of chronic fatigue syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Psychiatric disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/33/26135\">",
"           Antidepressant medication in adults: Switching and discontinuing medication",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/18/5417\">",
"           Atypical antidepressants: Pharmacology, administration, and side effects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/13/11481\">",
"           Clinical manifestations and diagnosis of depression",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/2/23593\">",
"           Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/63/44023\">",
"           Eating disorders: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/21/7512\">",
"           Factitious disorder and Munchausen syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/0/32776\">",
"           Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/8/40074\">",
"           Initial treatment of depression in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/25/7574\">",
"           Monoamine oxidase inhibitors (MAOIs) for treating depressed adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/0/5129\">",
"           Serotonin modulators: Pharmacology, administration, and side effects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/28/5578\">",
"           Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/61/27609\">",
"           Treatment of resistant depression in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/20/36169\">",
"           Unipolar depression in adults and tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/38/37481\">",
"           Unipolar depression in adults: Epidemiology, pathogenesis, and neurobiology",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Rheumatic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/55/8056\">",
"           Clinical manifestations and diagnosis of fibromyalgia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/49/35608\">",
"           Differential diagnosis of fibromyalgia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/43/37562\">",
"           Epidemiology and pathogenesis of systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/16/16646\">",
"           Menstrual function, menopause, and hormonal contraceptives in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/31/41464\">",
"           Overview of the clinical manifestations of systemic lupus erythematosus in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/38/41578\">",
"           Overview of the therapy and prognosis of systemic lupus erythematosus in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/19/31031\">",
"           Pathogenesis of fibromyalgia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Screening for cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/32/35337\">",
"           Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/49/41754\">",
"           Screening for breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/10/37034\">",
"           Screening for colorectal cancer: Strategies in patients at average risk",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/14/10474\">",
"           Screening for ovarian cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Sexually transmitted diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/15/12538\">",
"           Approach to the patient with genital ulcers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/0/1032\">",
"           Clinical features and diagnosis of pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/35/26166\">",
"           Diagnosis of gonococcal infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/44/39624\">",
"           Diagnostic testing for syphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/56/3976\">",
"           Disseminated gonococcal infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/10/9386\">",
"           Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/61/36823\">",
"           Epidemiology, clinical manifestations, and diagnosis of tuboovarian abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/20/38217\">",
"           Epidemiology, pathogenesis, and clinical manifestations of Neisseria gonorrhoeae infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/46/42728\">",
"           Genital Chlamydia trachomatis infections in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/35/16954\">",
"           HIV and women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/25/18837\">",
"           Laboratory monitoring of patients undergoing treatment for syphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/34/43560\">",
"           Management and complications of tuboovarian abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/44/26312\">",
"           Neurosyphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/45/11992\">",
"           Pathogenesis of and risk factors for pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/9/37017\">",
"           Pathogenesis, clinical manifestations, and treatment of early syphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/48/776\">",
"           Pathogenesis, clinical manifestations, and treatment of late syphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/55/12150\">",
"           Pathophysiology, transmission, and natural history of syphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/15/21751\">",
"           Prevention of genital herpes virus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/13/8408\">",
"           Screening for Chlamydia trachomatis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/32/7690\">",
"           Treatment of genital herpes simplex virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/63/35832\">",
"           Treatment of pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/53/26455\">",
"           Virology of human papillomavirus infections and the link to cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Urinary tract infection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/15/13561\">",
"           Acute uncomplicated cystitis and pyelonephritis in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/19/42295\">",
"           Approach to the adult with asymptomatic bacteriuria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/24/5514\">",
"           Recurrent urinary tract infection in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/41/24214\">",
"           Urine sampling and culture in the diagnosis of urinary tract infection in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Venous insufficiency/thromboembolism",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/57/6042\">",
"           Diagnosis of acute pulmonary embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/41/11930\">",
"           Evaluation of the patient with established venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/48/43786\">",
"           Overview of the causes of venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/32/42503\">",
"           Treatment of acute pulmonary embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/4/43082\">",
"           Treatment of lower extremity deep vein thrombosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Violence against women",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/7/20601\">",
"           Evaluation and management of adult sexual assault victims",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/15/6393\">",
"           Intimate partner violence: Diagnosis and screening",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/41/5784\">",
"           Intimate partner violence: Epidemiology and health consequences",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/54/14183\">",
"           Intimate partner violence: Intervention and patient management",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-85AC74B2F8-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f22_6_22624=[""].join("\n");
var outline_f22_6_22624=null;
var title_f22_6_22625="Patient information: Hiccups (The Basics)";
var content_f22_6_22625=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?24/2/24610\">",
"         Patient information: Acid reflux (gastroesophageal reflux disease) in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?37/30/38373\">",
"         Patient information: Acid reflux (gastroesophageal reflux disease) in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Hiccups (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/hiccups-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H11954436\">",
"      <span class=\"h1\">",
"       What are hiccups?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Hiccups happen when your diaphragm, the muscle that separates your chest from your belly, suddenly contracts. When that happens, you take in air, and then your voice box closes shut, which is what causes the &ldquo;hic&rdquo; sound.",
"     </p>",
"     <p>",
"      There are different types of hiccups, named after how long they last:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        A &ldquo;regular&rdquo; bout of hiccups can last up to 48 hours",
"       </li>",
"       <li>",
"        &ldquo;Persistent hiccups&rdquo; last longer than 48 hours and up to a month",
"       </li>",
"       <li>",
"        &ldquo;Intractable hiccups&rdquo; last longer than a month",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      In most cases, hiccups go away on their own with no lasting effects. But in some people, they can last a long time and lead to problems such as poor nutrition, tiredness, and reduced appetite.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11954451\">",
"      <span class=\"h1\">",
"       What causes hiccups?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The most common causes include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Having an overly full stomach",
"       </li>",
"       <li>",
"        Drinking soda or other fizzy drinks",
"       </li>",
"       <li>",
"        Swallowing air (for example when you are chewing gum)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      In rare situations, hiccups can have more serious causes, such as infections or irritation of a nerve in the neck or diaphragm.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11954466\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to get rid of the hiccups?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes, there are a few things you can try:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Hold your breath for several seconds or longer",
"       </li>",
"       <li>",
"        Breathe out against your closed mouth and nose (the way you might do on an airplane to pop your ears)",
"       </li>",
"       <li>",
"        Stimulate the back of your throat, for example by sipping cold water, gargling with water, or swallowing a teaspoon of sugar",
"       </li>",
"       <li>",
"        Pull your knees up to your chest and lean forward",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11954489\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse if you have hiccups that last longer than 48 hours. He or she will do an exam and ask about your symptoms. Most cases of hiccups are harmless. But the doctor or nurse might want to do a few tests, depending on your symptoms, medical history, and what the exam shows.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11954504\">",
"      <span class=\"h1\">",
"       How are hiccups treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If the self-help steps listed above do not help enough, there are a number of prescription medicines that can help. There are also procedures, such as acupuncture or surgery to treat hiccups, but they are only for people with extreme symptoms who do not get better with other treatments.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11954519\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/2/24610?source=see_link\">",
"       Patient information: Acid reflux (gastroesophageal reflux disease) in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?37/30/38373?source=see_link\">",
"       Patient information: Acid reflux (gastroesophageal reflux disease) in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?22/6/22625?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16542 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-42B5A9483A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22625=[""].join("\n");
var outline_f22_6_22625=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11954436\">",
"      What are hiccups?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11954451\">",
"      What causes hiccups?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11954466\">",
"      Is there anything I can do on my own to get rid of the hiccups?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11954489\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11954504\">",
"      How are hiccups treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11954519\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/30/38373?source=related_link\">",
"      Patient information: Acid reflux (gastroesophageal reflux disease) in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/2/24610?source=related_link\">",
"      Patient information: Acid reflux (gastroesophageal reflux disease) in adults (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_6_22626="Transfixion uterosacral ligamnt";
var content_f22_6_22626=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F72050&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F72050&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Suture transfixion of the uterosacral ligaments during vaginal hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 369px; height: 332px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The ligaments are attached to the posterior vaginal mucosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22626=[""].join("\n");
var outline_f22_6_22626=null;
var title_f22_6_22627="Taliglucerase alfa (glucocerebrosidase): Patient drug information";
var content_f22_6_22627=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Taliglucerase alfa (glucocerebrosidase): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/9/7316?source=see_link\">",
"     see \"Taliglucerase alfa (glucocerebrosidase): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F14279985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Elelyso&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F14286976\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691857",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Gaucher's disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F14286975\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3761724",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to taliglucerase or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F14286980\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F14286981\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698247",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle or joint pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever, chills, itching, hives, chest pain or pressure, or shortness of breath when drug is given. Other drugs may be given to avoid these.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Allergic side effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F14286982\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699037",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle or joint pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F14286978\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F14286984\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 85637 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-393BA8AD0C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22627=[""].join("\n");
var outline_f22_6_22627=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14279985\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14286976\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14286975\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14286980\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14286981\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14286982\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14286978\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14286984\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?7/9/7316?source=related_link\">",
"      Taliglucerase alfa (glucocerebrosidase): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_6_22628="Advanced case 13 with answer";
var content_f22_6_22628=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56316&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56316&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 525px\">",
"   <div class=\"ttl\">",
"    Atrial fibrillation and nonsustained ventricular tachycardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 505px; height: 127px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nonsustained ventricular tachycardia in a patient with underlying atrial fibrillation. The ventricular arrhythmia consists of nine beats at an approximate rate of 170 beats/min.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22628=[""].join("\n");
var outline_f22_6_22628=null;
var title_f22_6_22629="Fixed drug eruption with bulla";
var content_f22_6_22629=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F67733&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F67733&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Fixed drug eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple violaceous round&nbsp;plaques are present on the skin. A central bulla is present in one lesion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from:",
"     <a href=\"file://www.visualdx.com\" target=\"_blank\">",
"      www.visualdx.com",
"     </a>",
"     . Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22629=[""].join("\n");
var outline_f22_6_22629=null;
var title_f22_6_22630="Role of surgery in patients with metastatic renal cell carcinoma";
var content_f22_6_22630=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Role of surgery in patients with metastatic renal cell carcinoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/6/22630/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/6/22630/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/6/22630/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/6/22630/contributors\">",
"     Michael B Atkins, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/6/22630/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/6/22630/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/6/22630/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who present with metastatic renal cell carcinoma (RCC) or who develop metastases or recurrent disease following prior treatment are generally managed with systemic therapy, using either high-dose interleukin-2 (IL-2) or molecularly targeted agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/14/12522?source=see_link\">",
"     \"Immunotherapy of renal cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28170?source=see_link\">",
"     \"Anti-angiogenic and molecularly targeted therapy for advanced renal cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgery may play a role in the management of carefully selected patients with metastatic RCC in one of several ways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cytoreductive nephrectomy, as part of a combined modality approach, to decrease the bulk of tumor prior to systemic therapy",
"     </li>",
"     <li>",
"      Metastasectomy, in patients with one or a very limited number of metastases",
"     </li>",
"     <li>",
"      Palliative nephrectomy, to control severe local and systemic symptoms from the primary tumor",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The role of surgery in the initial management of patients with localized RCC is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/26/5546?source=see_link\">",
"     \"Surgical management of localized renal cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CYTOREDUCTIVE NEPHRECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although patients with metastatic renal cell carcinoma (RCC) generally have a poor prognosis, regression of metastatic disease has been reported following removal of the primary tumor (cytoreductive or debulking nephrectomy). However, this is seen in less than one percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4255571\">",
"    <span class=\"h2\">",
"     Role of postoperative immunotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest postoperative immunotherapy for carefully selected patients with clear cell RCC who undergo cytoreductive nephrectomy because randomized trials have shown this approach results in a survival benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. However, a survival benefit has not been established for patients with non-clear cell tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/14/12522?source=see_link&amp;anchor=H26#H26\">",
"     \"Immunotherapy of renal cell carcinoma\", section on 'Cytoreductive (debulking) nephrectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Two randomized trials support a role for cytoreductive nephrectomy in carefully selected patients who subsequently undergo immunotherapy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Southwest Oncology Group (SWOG) randomly assigned 246 patients presenting with metastatic RCC to immediate IFNa (5",
"      <span class=\"nowrap\">",
"       mU/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      three times weekly) or to initial nephrectomy followed by IFNa [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/3\">",
"       3",
"      </a>",
"      ]. The median survival was significantly better for patients undergoing cytoreductive nephrectomy compared to immediate IFNa (11 versus 8 months).",
"     </li>",
"     <li>",
"      A similar benefit was noted in an identically designed trial of 83 patients with metastatic disease, sponsored by the European Organisation for Research and Treatment of Cancer (EORTC) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/2\">",
"       2",
"      </a>",
"      ]. Both time to progression (5 versus 3 months) and median survival duration (17 versus 7 months) significantly favored cytoreductive nephrectomy prior to immunotherapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The possible benefit of retroperitoneal lymphadenectomy in the context of cytoreductive nephrectomy and immunotherapy for patients presenting with stage IV disease has not been well studied (",
"    <a class=\"graphic graphic_table graphicRef54563 \" href=\"UTD.htm?14/54/15213\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. At least one report suggests that there is no advantage to this approach [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/5\">",
"     5",
"    </a>",
"    ]. Other data suggest that the presence of retroperitoneal nodes is a strong predictor of failure to achieve an objective response or improved survival when immunotherapy is administered after cytoreductive nephrectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4255752\">",
"    <span class=\"h2\">",
"     Role of molecularly targeted agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of cytoreductive nephrectomy in patients who receive molecularly targeted agents has not been established in randomized trials. In the absence of clinical trials data, the general consensus is to perform cytoreductive nephrectomy in appropriately selected patients followed by molecularly targeted therapy. (See",
"    <a class=\"local\" href=\"#H4255504\">",
"     'Patient selection'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28170?source=see_link\">",
"     \"Anti-angiogenic and molecularly targeted therapy for advanced renal cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Support for this approach comes from an observational study of 314 patients treated with molecularly targeted agents, including 201 who underwent cytoreductive nephrectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/8\">",
"     8",
"    </a>",
"    ]. Patients who underwent cytoreductive nephrectomy had a significantly longer overall survival than those who did not have surgery (20 versus 9 months). This benefit persisted on multivariate analysis after adjusting for other known risk factors (hazard ratio 0.68, 95% CI 0.46-0.99). The",
"    <a class=\"external\" href=\"file://clinicaltrials.gov/show/NCT00930033\">",
"     Clinical Trial to Assess the Importance of Nephrectomy (CARMENA)",
"    </a>",
"    is in progress in Europe to address the value of nephrectomy prior to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/10/44200?source=see_link\">",
"     sunitinib",
"    </a>",
"    therapy for metastatic RCC [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4255504\">",
"    <span class=\"h2\">",
"     Patient selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with metastatic, clear cell RCC, a good performance status, and resectable primary tumors should be considered for cytoreductive nephrectomy.",
"   </p>",
"   <p>",
"    However, some patients who first undergo cytoreductive nephrectomy never receive systemic therapy due to surgical complications or rapid disease progression. As a result, selection of patients to undergo cytoreductive nephrectomy should be done with considerable care. Laparoscopic nephrectomy may be useful in carefully selected patients to minimize morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one series, use of the following criteria enabled over 90 percent of patients to receive immunotherapy following surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Greater than 75 percent tumor debulking possible",
"     </li>",
"     <li>",
"      ECOG performance status of 0 or 1 (",
"      <a class=\"graphic graphic_table graphicRef72901 \" href=\"UTD.htm?9/15/9467\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Adequate pulmonary and cardiac function",
"     </li>",
"     <li>",
"      Biopsy, if performed prior to surgery, shows clear cell histology",
"     </li>",
"     <li>",
"      Exclusion of patients with extensive liver or bone metastases or any central nervous system involvement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other approaches have been proposed for patient selection. As an example, one large series used combination of pretreatment laboratory parameters (LDH, serum albumin), sites of metastatic disease, and clinical tumor (T) stage to assist in predicting overall survival [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/12\">",
"     12",
"    </a>",
"    ]. However, the use of this approach may need to be reevaluated in the era of molecularly targeted agents.",
"   </p>",
"   <p>",
"    A multidisciplinary consultation that includes discussion of the patient's prognosis, radiological features of the primary and metastatic sites, the proposed systemic treatment options, and the potential need for establishing a histologic diagnosis prior to surgery is recommended to establish an appropriate plan for each patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     METASTASECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resection of metastatic disease (metastasectomy) has been performed in several situations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Patients presenting with stage IV disease at presentation, where it is performed with nephrectomy",
"     </li>",
"     <li>",
"      Patients who develop metastatic disease following nephrectomy",
"     </li>",
"     <li>",
"      Patients who have persistent disease despite systemic therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Metastatic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest surgery for patients who are candidates for complete resection of all metastatic disease rather than systemic therapy alone. The potential role of surgery is illustrated by the results from a series of 278 patients with recurrent renal cell carcinoma (RCC), in which 51 percent underwent removal of all of their metastatic disease with curative intent, 25 percent underwent partial resection of their metastatic disease, and 24 percent were treated without surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/13\">",
"     13",
"    </a>",
"    ]. Metastases were most frequently resected from lung, brain, bone, and soft tissue.",
"   </p>",
"   <p>",
"    The following findings were noted on multivariate analysis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The five-year overall survival rate was highest in patients treated with curative intent metastasectomy (44 versus 14 and 11 percent, respectively). Survival rates after complete resection of a second and third metastasis were not different from those after initial metastasectomy.",
"     </li>",
"     <li>",
"      The strongest predictors of prolonged survival were a disease-free interval from nephrectomy to detection of metastases of greater than one year (55 versus 9 percent five-year overall survival), a single site versus multiple sites of metastases (54 versus 29 percent five-year survival), especially if the site was the lung, Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (",
"      <a class=\"graphic graphic_table graphicRef72901 \" href=\"UTD.htm?9/15/9467\">",
"       table 2",
"      </a>",
"      ), and the absence of prior cytotoxic chemotherapy or of significant recent weight loss.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1462133\">",
"    <span class=\"h2\">",
"     Organ-specific considerations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Lung metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical resection of isolated lung metastases in carefully selected patients has been associated with a 20 to 50 percent five-year survival. The criteria, techniques, and results for surgical resection of pulmonary metastases are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13560?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Outcomes by histology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Isolated bone metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excision of bone metastases may be considered in carefully selected patients for both pain relief and tumor control [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. In one series, 295 consecutive patients with metastatic RCC who had a solitary lesion, intractable pain, or impending fracture underwent resection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/16\">",
"     16",
"    </a>",
"    ]. Overall, the one and five year survival rates were 47 and 11 percent. The best results were seen in patients who had either a solitary bone lesion or multiple, bone-only metastases. Surgical excision should be considered as a reasonable alternative to radiation therapy in patients with a solitary or dominant symptomatic bone metastasis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33924?source=see_link\">",
"     \"Radiation therapy for the management of painful bone metastases\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Brain metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery is used to provide rapid relief of symptoms resulting from the mass effect of a brain metastasis in patients with RCC. Some patients with a solitary metastasis from RCC may have prolonged survival after local therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/35/44601?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment of brain metastases in favorable prognosis patients\", section on 'Surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Local recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the majority of patients who develop a local soft tissue recurrence die of metastatic disease, resection may result in prolonged survival [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. As with metastatic disease, patients with a longer time to recurrence following nephrectomy, and small volume recurrent disease tend to do better. Resection of locally recurrent disease may be particularly useful in patients with papillary or chromophobe type renal cancer, situations in which systemic treatment options are extremely limited and distant metastatic disease less likely.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1462103\">",
"    <span class=\"h2\">",
"     Role of systemic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who undergo complete resection of metastatic disease, surveillance is recommended. Outside of a research protocol setting, systemic therapy should be reserved for patients with measurable disease. The Eastern Cooperative group is currently conducting a",
"    <a class=\"external\" href=\"file://clinicaltrials.gov/show/NCT01575548\">",
"     randomized phase III trial",
"    </a>",
"    of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/2/1064?source=see_link\">",
"     pazopanib",
"    </a>",
"    versus placebo in patients following complete resection of stage IV disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/38/32360?source=see_link\">",
"     \"Surveillance for metastatic disease after nephrectomy for renal cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/1/21528?source=see_link\">",
"     \"Overview of the treatment of renal cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1462257\">",
"    <span class=\"h2\">",
"     Residual disease after systemic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resection of metastatic disease appears to be effective following systemic therapy in carefully selected patients.",
"   </p>",
"   <p>",
"    Resection of residual disease after achieving a partial remission to systemic therapy with IL-2 frequently has resulted in disease-free survival for significant periods [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. This was illustrated in a series of 31 selected patients with RCC who had a partial or complete response to systemic IL-2 and then underwent resection of relapsing or residual disease; the two-year progression-free survival was 37 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/22\">",
"     22",
"    </a>",
"    ]. Subsequent evaluation has confirmed that most of these patients remain disease-free, with follow-up beyond 10 years in some cases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/14\">",
"     14",
"    </a>",
"    ]. Pathology of the resected lesions frequently reveals an active lymphoid infiltrate surrounding the residual tumor or occasionally no evidence of residual tumor. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/14/12522?source=see_link&amp;anchor=H16#H16\">",
"     \"Immunotherapy of renal cell carcinoma\", section on 'Relapses after response'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Data for patients treated initially with targeted therapy is more limited and of shorter duration but also supports the role of metastasectomy in appropriately selected patients. In an observational multicenter series of 22 patients, 11 remained disease-free at a median of 43 weeks after surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/23\">",
"     23",
"    </a>",
"    ]. Overall, 21 patients were alive at a median follow-up of over two years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PALLIATIVE NEPHRECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nephrectomy has been used to control severe local and systemic symptoms from the primary tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22630/abstract/24,25\">",
"     24,25",
"    </a>",
"    ], although the majority of these complaints can be effectively treated without surgery.",
"   </p>",
"   <p>",
"    Alternative approaches to symptom palliation are illustrated by the following examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pain and bleeding can be managed with analgesics or angioinfarction.",
"     </li>",
"     <li>",
"      The consequences of colic due to obstruction with clot can be minimized by ureteral stents and hydration.",
"     </li>",
"     <li>",
"      Hypercalcemia, fatigue, fever, and other systemic symptoms are often controlled with nonsteroidal antiinflammatory drugs, bisphosphonates, hydration,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      appetite stimulants. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/42/16041?source=see_link\">",
"       \"Treatment of hypercalcemia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who present with metastatic renal cell carcinoma (RCC) or who develop metastases or recurrent disease following prior treatment are generally managed with systemic therapy, using either high-dose interleukin-2 (IL-2) or molecularly targeted agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/14/12522?source=see_link\">",
"     \"Immunotherapy of renal cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28170?source=see_link\">",
"     \"Anti-angiogenic and molecularly targeted therapy for advanced renal cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgery retains an important role in the management of carefully selected patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who have metastatic clear cell RCC at presentation, a good performance status, and a resectable primary tumor, we suggest debulking nephrectomy rather than systemic therapy alone (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4255571\">",
"       'Role of postoperative immunotherapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4255752\">",
"       'Role of molecularly targeted agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with limited tumor burden following completion of immunotherapy, we recommend metastasectomy rather than observation (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). This approach has been associated with prolonged disease-free survival in a substantial fraction of patients. (See",
"      <a class=\"local\" href=\"#H1462257\">",
"       'Residual disease after systemic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with a single or limited number of resectable metastases at presentation or relapse following initial treatment, we suggest metastasectomy rather than systemic therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Metastatic disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/1\">",
"      Elhilali MM, Gleave M, Fradet Y, et al. Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma. The Canadian Urologic Oncology Group. BJU Int 2000; 86:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/2\">",
"      Mickisch GH, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001; 358:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/3\">",
"      Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001; 345:1655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/4\">",
"      Kassouf W, Sanchez-Ortiz R, Tamboli P, et al. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology. J Urol 2007; 178:1896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/5\">",
"      Vasselli JR, Yang JC, Linehan WM, et al. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. J Urol 2001; 166:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/6\">",
"      Pantuck AJ, Zisman A, Dorey F, et al. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. Cancer 2003; 97:2995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/7\">",
"      Pantuck AJ, Zisman A, Dorey F, et al. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 2003; 169:2076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/8\">",
"      Choueiri TK, Xie W, Kollmannsberger C, et al. The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy. J Urol 2011; 185:60.",
"     </a>",
"    </li>",
"    <li>",
"     ClinicalTrials.gov file://www.clinicaltrials.gov/ (Accessed on October 27, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/10\">",
"      Matin SF, Madsen LT, Wood CG. Laparoscopic cytoreductive nephrectomy: the M. D. Anderson Cancer Center experience. Urology 2006; 68:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/11\">",
"      Fallick ML, McDermott DF, LaRock D, et al. Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma. J Urol 1997; 158:1691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/12\">",
"      Culp SH, Tannir NM, Abel EJ, et al. Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? Cancer 2010; 116:3378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/13\">",
"      Kavolius JP, Mastorakos DP, Pavlovich C, et al. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998; 16:2261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/14\">",
"      Yang JC, Abad J, Sherry R. Treatment of oligometastases after successful immunotherapy. Semin Radiat Oncol 2006; 16:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/15\">",
"      Kollender Y, Bickels J, Price WM, et al. Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention. J Urol 2000; 164:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/16\">",
"      Lin PP, Mirza AN, Lewis VO, et al. Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg Am 2007; 89:1794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/17\">",
"      Shuch B, La Rochelle JC, Klatte T, et al. Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer 2008; 113:1641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/18\">",
"      Schrodter S, Hakenberg OW, Manseck A, et al. Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma. J Urol 2002; 167:1630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/19\">",
"      Itano NB, Blute ML, Spotts B, Zincke H. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 2000; 164:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/20\">",
"      Margulis V, McDonald M, Tamboli P, et al. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma. J Urol 2009; 181:2044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/21\">",
"      Fleischmann JD, Kim B. Interleukin-2 immunotherapy followed by resection of residual renal cell carcinoma. J Urol 1991; 145:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/22\">",
"      Lee DS, White DE, Hurst R, et al. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy. Cancer J Sci Am 1998; 4:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/23\">",
"      Karam JA, Rini BI, Varella L, et al. Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma. J Urol 2011; 185:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/24\">",
"      Flanigan RC. Role of surgery in metastatic renal cell carcinoma. Semin Urol 1989; 7:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22630/abstract/25\">",
"      Middleton AW Jr. Indications for and results of nephrectomy for metastatic renal cell carcinoma. Urol Clin North Am 1980; 7:711.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2963 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-3033BD7A4C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22630=[""].join("\n");
var outline_f22_6_22630=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CYTOREDUCTIVE NEPHRECTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4255571\">",
"      Role of postoperative immunotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4255752\">",
"      Role of molecularly targeted agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4255504\">",
"      Patient selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      METASTASECTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Metastatic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1462133\">",
"      Organ-specific considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Lung metastases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Isolated bone metastases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Brain metastases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Local recurrence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1462103\">",
"      Role of systemic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1462257\">",
"      Residual disease after systemic therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PALLIATIVE NEPHRECTOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2963\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2963|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/54/15213\" title=\"table 1\">",
"      TNM staging RCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/15/9467\" title=\"table 2\">",
"      ECOG performance scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28170?source=related_link\">",
"      Anti-angiogenic and molecularly targeted therapy for advanced renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/14/12522?source=related_link\">",
"      Immunotherapy of renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/1/21528?source=related_link\">",
"      Overview of the treatment of renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33924?source=related_link\">",
"      Radiation therapy for the management of painful bone metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/26/5546?source=related_link\">",
"      Surgical management of localized renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=related_link\">",
"      Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13560?source=related_link\">",
"      Surgical resection of pulmonary metastases: Outcomes by histology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/38/32360?source=related_link\">",
"      Surveillance for metastatic disease after nephrectomy for renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/35/44601?source=related_link\">",
"      Treatment of brain metastases in favorable prognosis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/42/16041?source=related_link\">",
"      Treatment of hypercalcemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_6_22631="Barretts esoph Alcian blue";
var content_f22_6_22631=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F68357&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F68357&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Barrett's esophagus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 408px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power view of a biopsy specimen from a patient with Barrett's esophagus has been stained with Alcian blue, which demonstrates the abundant goblet cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Lewin KJ, Appelman HD. Tumors of the esophagus and stomach. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 18, 1996, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22631=[""].join("\n");
var outline_f22_6_22631=null;
var title_f22_6_22632="Clinical features and diagnosis of heme pigment-induced acute kidney injury (acute renal failure)";
var content_f22_6_22632=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of heme pigment-induced acute kidney injury (acute renal failure)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/6/22632/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/6/22632/contributors\">",
"     Joseph A Eustace, MB, MHS, MRCPI",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/6/22632/contributors\">",
"     Sinead Kinsella, MD, MBS, MRCPI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/6/22632/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/6/22632/contributors\">",
"     Paul M Palevsky, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/6/22632/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/6/22632/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/6/22632/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H11512141\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute kidney injury (AKI) can occur in patients who have rhabdomyolysis and, less commonly, in patients with hemolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In both groups, AKI is caused by the non-protein heme pigment that is released from either myoglobin or hemoglobin and is toxic to the kidney. Hypovolemia may contribute in patients with rhabdomyolysis due to crush injury.",
"   </p>",
"   <p>",
"    The clinical features and diagnosis of heme pigment-induced AKI due to nontraumatic rhabdomyolysis and to hemolysis will be reviewed here. Prevention and treatment of heme pigment-induced AKI, AKI due to crush injury, and overviews of rhabdomyolysis and hemolysis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21847?source=see_link\">",
"     \"Prevention and treatment of heme pigment-induced acute kidney injury (acute renal failure)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15369?source=see_link\">",
"     \"Crush-related acute kidney injury (acute renal failure)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link\">",
"     \"Approach to the diagnosis of hemolytic anemia in the adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512148\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heme pigment-containing proteins include myoglobin and hemoglobin. Myoglobin is released from muscle in patients with traumatic or nontraumatic rhabdomyolysis, whereas hemoglobin is released from hemolyzed red blood cells. Both myoglobin and hemoglobin are filtered by the glomerulus into the urinary space, where they are degraded thus releasing heme pigment.",
"   </p>",
"   <p>",
"    Heme pigment may injure the kidney in three ways:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Tubular obstruction, possibly in association with uric acid [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/1,3\">",
"       1,3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Direct proximal tubular cell injury [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/1,4,5\">",
"       1,4,5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Vasoconstriction, which results in a reduction in blood flow in the outer medulla [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite its toxic properties, heme pigment rarely causes kidney injury in the absence of predisposing conditions, which include volume depletion, acidosis and, possibly, mild ischemia.",
"   </p>",
"   <p>",
"    Volume depletion enhances both vasoconstriction and the formation of obstructing casts, and has been shown in both animal models [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/1,3\">",
"     1,3",
"    </a>",
"    ] and human studies [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/6,7\">",
"     6,7",
"    </a>",
"    ] to be critically important for the development of heme-induced AKI. The importance of concurrent volume depletion was demonstrated in studies of military recruits undergoing intensive training and in patients with myopathies; whereas myoglobinuria is frequently present in such patients, the development of AKI is unusual providing euvolemia is maintained [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An acidic urine may also favor cast formation and proximal tubular cell injury [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/1,3,5\">",
"     1,3,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512155\">",
"    <span class=\"h2\">",
"     Causes of rhabdomyolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of rhabdomyolysis are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"    </a>",
"    .) In general rhabdomyolysis results from the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Traumatic muscle injury",
"     </li>",
"     <li>",
"      Increased voluntary or involuntary muscle activity.",
"     </li>",
"     <li>",
"      Exogenous toxins including alcohol, illicit drugs, or polypharmacy",
"     </li>",
"     <li>",
"      Hereditary myopathies and inflammatory muscle diseases",
"     </li>",
"     <li>",
"      Hypokalemia, hyperphosphatemia and hyperosmolality",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512162\">",
"    <span class=\"h2\">",
"     Causes of hemolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are numerous causes of intravascular hemolysis, few of which are commonly encountered in clinical practice. An introduction to this topic can be found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link\">",
"     \"Approach to the diagnosis of hemolytic anemia in the adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ABO-incompatible blood transfusions used to be the most common cause of hemolysis-associated AKI; these are now quite rare due to improved blood banking practices [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/8\">",
"     8",
"    </a>",
"    ]. In the absence of transfusion-related causes, hemolysis is rarely an isolated cause of AKI. In modern practice, AKI that develops in the setting of hemolysis is usually multifactorial.",
"   </p>",
"   <p>",
"    The following causes of hemoglobinuria have been associated with AKI:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Glucose-6-phosphate dehydrogenase (G6PD) deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/9-11\">",
"       9-11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Poisoning [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/12\">",
"       12",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Snake and insect bites (envenomation) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/13\">",
"       13",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Drug reactions (cephalosporins) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Paroxysmal nocturnal hemoglobinuria (PNH) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/16-18\">",
"       16-18",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Malaria (Blackwater fever) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/19\">",
"       19",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Envenomation and poisonings often cause concurrent rhabdomyolysis and hemolysis, as well as immune complex mediated glomerulonephritis, interstitial nephritis, and hemolytic uremic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/12,13,20,21\">",
"     12,13,20,21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43833?source=see_link\">",
"     \"Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Malaria-associated AKI may be attributed to hemolysis in select cases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/19,22\">",
"     19,22",
"    </a>",
"    ], however other mechanisms including the mechanical obstruction caused by infected red blood cells, cytokine-mediated injury, and immune complex deposition usually play equally if not more important roles in its pathogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hemolysis related to cardiopulmonary bypass circuits, transfusion of stored red blood cells and cell salvage devices may contribute to AKI that occurs following cardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512169\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 26,000 diagnosed cases of rhabdomyolysis occur yearly in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/24\">",
"     24",
"    </a>",
"    ]. The reported percentage of cases that are complicated by AKI ranges from 15 to over 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/7,25,26\">",
"     7,25,26",
"    </a>",
"    ]. The variability in the reported incidence of AKI is likely related to differences in the severity of underlying rhabdomyolysis and varying definitions of AKI [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an example, in one retrospective series of 148 patients in which rhabdomyolysis was defined as creatine kinase (CK) &gt;1000",
"    <span class=\"nowrap\">",
"     U/L,",
"    </span>",
"    29 percent developed serum creatinine elevations &gt;2.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (177",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/27\">",
"     27",
"    </a>",
"    ]. In other reports, more severe rhabdomyolysis characterized by much higher CK levels, as may be seen following earthquakes, led to AKI requiring dialysis in 50 to 65 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15369?source=see_link\">",
"     \"Crush-related acute kidney injury (acute renal failure)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The incidence of AKI as a result of hemolysis is variable. In an early description of massive hemolysis that resulted from the accidental infusion of hypotonic albumin solution, AKI occurred in five of ten patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/28\">",
"     28",
"    </a>",
"    ]. However, as noted previously, massive hemolysis has become uncommon in developed countries due to better transfusion practices. In current practice, among patients with hemolysis, AKI is much more likely to be multifactorial and less likely to be attributed to hemolysis alone [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512176\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with heme-associated AKI initially present with the manifestations of rhabdomyolysis or hemolysis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37766?source=see_link\">",
"     \"Transfusion-associated immune and non immune-mediated hemolysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/34/6697?source=see_link\">",
"     \"Extrinsic nonimmune hemolytic anemia due to systemic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Marked release of hemoglobin or myoglobin typically leads to red or brown urine, unless pigment excretion is limited because of a low glomerular filtration rate or clearance from the plasma by extrarenal mechanisms [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The plasma is typically normal in color in patients with rhabdomyolysis but may be reddish brown in patients who have sufficient hemolysis to cause hemoglobinuria. The red color of plasma in patients with hemolysis is due to the accumulation of hemoglobin. Hemoglobin is poorly filtered, due both to its large size (mol wt 69,000 of tetramer and 34,000 of dimer) and protein binding to haptoglobin. As a result, hemoglobinuria requires a relatively high plasma hemoglobin concentration.",
"   </p>",
"   <p>",
"    Myoglobin, in comparison, is a smaller molecule (mol wt 17,000) and is not protein bound. As a result, myoglobin is rapidly filtered and excreted and plasma retains its normal color unless renal failure limits myoglobin excretion.",
"   </p>",
"   <p>",
"    In the setting of normal renal function, the concentration of myoglobin necessary to visibly color plasma (approximately 100",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    would likely require a fatal degree of rhabdomyolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with rhabdomyolysis typically present with the triad of pigmented granular casts in the urine, a red to brown color of the urine supernatant, and a marked elevation in the plasma CK level [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/26,30\">",
"     26,30",
"    </a>",
"    ]. Patients with hemolysis have the same urinary findings, but a reduced haptoglobin, and an abnormal peripheral blood smear [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/31\">",
"     31",
"    </a>",
"    ]. An increased serum lactate dehydrogenase may be seen in both disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/34/22058?source=see_link&amp;anchor=H4#H4\">",
"     \"Urinalysis in the diagnosis of kidney disease\", section on 'Red to brown urine'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with either rhabdomyolysis or hemolysis may be oliguric or anuric.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512183\">",
"    <span class=\"h2\">",
"     Urinalysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urinalysis is similar among patients with AKI due to either rhabdomyolysis or hemolysis. The standard urinary orthotolidine dipstick tests positive in the presence of heme from myoglobin or hemoglobin, or due to red cells. Thus, dipstick positive microhematuria in the absence of any visible red cell by microscopy may signal the presence of either hemoglobinuria or myoglobinuria [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/32\">",
"     32",
"    </a>",
"    ]. Varying degrees of proteinuria may also be found on urinalysis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/7\">",
"     7",
"    </a>",
"    ]. Heme pigment may combine with Tamm-Horsfall protein to give rise to characteristic pigmented granular casts on urine microscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast to other forms of acute tubular necrosis, the fractional excretion of sodium is often less than 1 percent in patients with AKI from either hemolysis or rhabdomyolysis, possibly reflecting renal vasoconstriction and concurrent volume depletion that is commonly observed. (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?25/13/25809?source=see_link\">",
"     calculator 1",
"    </a>",
"    and",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?24/28/25025?source=see_link\">",
"     calculator 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/34\">",
"     34",
"    </a>",
"    ]. The low fractional sodium excretion may be observed even with established tubular injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/17/8472?source=see_link\">",
"     \"Fractional excretion of sodium, urea, and other molecules in acute kidney injury (acute renal failure)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512190\">",
"    <span class=\"h2\">",
"     Other laboratory findings",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512198\">",
"    <span class=\"h3\">",
"     Creatine kinase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with rhabdomyolysis, creatine kinase (CK) is released from injured muscle into the circulation, resulting in a dramatic (sometimes over 1000-fold) increase in its serum concentration. Levels peak within 24 hours of a focal muscle injury and thereafter decline by 50 percent per 48 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The degree of CK elevation does not always predict the development of AKI, although there is a weak correlation between the peak CK level and the serum creatinine [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/1\">",
"     1",
"    </a>",
"    ]. In one study, 58 percent of patients with rhabdomyolysis who developed acute renal failure had peak CK levels greater than 16,000",
"    <span class=\"nowrap\">",
"     U/L",
"    </span>",
"    compared to only 11 percent in those who did not develop acute renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/26\">",
"     26",
"    </a>",
"    ]. AKI is uncommon when peak CK levels are under 5,000 to 10,000",
"    <span class=\"nowrap\">",
"     U/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/36-39\">",
"     36-39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The predominant form of CK released from damaged striated muscles is the MM isoform, although a small quantity of the MB isoform may also be released. As a result, mildly elevated CK MB levels may be seen in the absence of any myocardial involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Peak plasma myoglobin levels may correlate more closely than the CK with acute renal failure, but this test is less commonly used in clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/26,36\">",
"     26,36",
"    </a>",
"    ]. Myoglobin has a shorter half life (three hours) than CK and is normally cleared from the plasma by hepatic metabolism to bilirubin and, to a lesser extent, by glomerular filtration and renal metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/42\">",
"     42",
"    </a>",
"    ]. Thus, although myoglobinemia may precede the rise in CK, it will likely have resolved by the time the patient presents with AKI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512205\">",
"    <span class=\"h3\">",
"     Potassium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with either rhabdomyolysis or hemolysis, hyperkalemia may develop early even in the absence of AKI, due to the release of intracellular potassium into the extracellular fluid. The severity of hyperkalemia may appear disproportionate to the degree of renal injury and the serum potassium may increase rapidly despite the absence of exogenous potassium administration. The daily rate of rise in the plasma potassium concentration may exceed 1.0",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in patients with rhabdomyolysis or other hypercatabolic states [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/43\">",
"     43",
"    </a>",
"    ], much greater than typically occurs with renal failure in patients who are not hypercatabolic (maximum daily rate of rise of 0.3",
"    <span class=\"nowrap\">",
"     meq/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hyperkalemia causes severe manifestations acutely, and thus should be appropriately treated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/54/17258?source=see_link\">",
"     \"Treatment and prevention of hyperkalemia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512212\">",
"    <span class=\"h3\">",
"     Calcium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities of serum calcium are common among patients with rhabdomyolysis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypocalcemia occurs in up to two-thirds of patients with significant rhabdomyolysis and is due to the increase in serum phosphate and the subsequent deposition of calcium phosphate into injured muscle, as well as decreased bone responsiveness to parathyroid hormone [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hypercalcemia occurs during the recovery phase of rhabdomyolysis in up to 20 to 30 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/45,46\">",
"       45,46",
"      </a>",
"      ]. This is due, in part, to the mobilization of calcium that has been deposited in the injured muscle [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/46,47\">",
"       46,47",
"      </a>",
"      ]. Mild secondary hyperparathyroidism in the setting of renal dysfunction; correction of hyperphosphatemia (resulting from the rise in glomerular filtration rate) and an unexplained increase in calcitriol (1,25-dihydroxyvitamin D) may contribute to this response [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/45-48\">",
"       45-48",
"      </a>",
"      ]. To minimize this complication, the administration of calcium should be avoided during the renal failure phase unless the patient has symptomatic hypocalcemia or severe hyperkalemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44632?source=see_link\">",
"       \"Treatment of hypocalcemia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/54/17258?source=see_link\">",
"       \"Treatment and prevention of hyperkalemia in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512226\">",
"    <span class=\"h3\">",
"     Phosphate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperphosphatemia and a mild to moderate high anion gap acidosis may be seen due to the release of intracellular phosphate and organic acids [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/25\">",
"     25",
"    </a>",
"    ]. The release of phosphate from damaged muscle cells frequently induces a confounding variable in patients with hypophosphatemia-induced rhabdomyolysis, since the underlying hypophosphatemia may be masked [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/49\">",
"     49",
"    </a>",
"    ]. In this setting, the demonstration of a low plasma phosphate concentration before or after the peak muscle breakdown may be the only clue to the presence of phosphate depletion.",
"   </p>",
"   <p>",
"    Hypocalcemia and hyperphosphatemia are not significant features of hemolysis in the absence of AKI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512233\">",
"    <span class=\"h3\">",
"     Creatinine-to-urea ratio",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been suggested that patients with rhabdomyolysis have an increased creatinine-to-urea ratio attributable to the conversion of intra-myocyte creatine to creatinine [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/30\">",
"     30",
"    </a>",
"    ]. However, this finding likely results from the more common occurrence of traumatic rhabdomyolysis in younger subjects who have a greater muscle mass compared to patients who develop AKI from other causes and are more frequently older and chronically ill [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512240\">",
"    <span class=\"h3\">",
"     Transaminases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intra-myocyte enzymes, including AST, ALT, LDH, and aldolase may be increased in patients with rhabdomyolysis; these may be the first biochemical abnormalities to be detected. As a result, these laboratory abnormalities are often initially misinterpreted as indicating liver disease. LDH is usually elevated among patients with hemolysis, although AST, ALT and aldolase are generally normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512247\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperuricemia may be present due to the release of nucleosides from damaged myocyte nuclei, which are metabolized in the liver into purines and then converted to uric acid. Thromboplastin release from cells resulting in the development of disseminated intravascular coagulation has been reported in patients with rhabdomyolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to the laboratory abnormalities described above, hemolysis is characterized by anemia, a reduced haptoglobin level, a positive direct antiglobulin test (Coombs test) and an abnormal blood smear with increased reticulocytes and spherocytic red cells. The CK is usually normal in patients with hemolysis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link\">",
"     \"Approach to the diagnosis of hemolytic anemia in the adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512254\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of heme-induced AKI is strongly suggested by oliguria in the setting of either known rhabdomyolysis or hemolysis. As patients may be unable to provide a reliable history, the diagnosis relies heavily on the assessment of the clinical circumstances and an appreciation of the underlying potential for either rhabdomyolysis or hemolysis.",
"   </p>",
"   <p>",
"    The presence of dipstick microhematuria in the absence of visible red cells by urine microscopy is compatible with both rhabdomyolysis and hemolysis. Urine sediment demonstrating dark brown granular casts suggests the diagnosis of ATN. As described above, in contrast to other forms of acute tubular necrosis, the fractional excretion of sodium is often less than 1 percent. (See",
"    <a class=\"local\" href=\"#H11512183\">",
"     'Urinalysis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A markedly elevated serum CK level (ie, greater than 20,000 to 30,000",
"    <span class=\"nowrap\">",
"     U/L)",
"    </span>",
"    is diagnostic of rhabdomyolysis though a 5- to 10-fold increase in levels above the population reference range (or approximately 1000",
"    <span class=\"nowrap\">",
"     U/L)",
"    </span>",
"    also suggests clinically relevant rhabdomyolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/53\">",
"     53",
"    </a>",
"    ]. More minor elevations are relatively common and often asymptomatic. However, the interpretation of the CK level must take into account the interval from time of injury to presentation, as levels quickly decline from their peak value. CK levels may also be lower in patients with liver disease or multi-organ failure, possibly due to decreased half-life of the enzyme in the circulation, as a result of extracellular glutathione depletion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although an elevated myoglobin level is also diagnostic of rhabdomyolysis, this test is only mildly to moderately sensitive. Tests of myoglobinuria, are unreliable and should not be used for screening [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/32\">",
"     32",
"    </a>",
"    ]. In general, there is little diagnostic utility in routinely monitoring intra-myocyte enzyme levels other than CK [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22632/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hemolysis is strongly suggested by reddish discoloration of plasma and by an increased serum LDH. Hemolysis is confirmed by the demonstration of increased reticulocytes and spherocytic red cells on the peripheral smear, increased reticulocyte percentage, a reduced or absent level of serum haptoglobin, and a positive Coombs test. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link\">",
"     \"Approach to the diagnosis of hemolytic anemia in the adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11512261\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute kidney injury (AKI) may occur in patients who have rhabdomyolysis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hemolysis. AKI is caused by the non-protein heme pigment that is released from either myoglobin or hemoglobin and is toxic to the kidney. Predisposing conditions that contribute to heme pigment-induced injury include volume depletion, acidosis and, possibly, mild ischemia. (See",
"      <a class=\"local\" href=\"#H11512141\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The major causes of rhabdomyolysis include traumatic muscle injury, increased voluntary or involuntary muscle activity, exogenous toxins including alcohol and illicit drugs, hereditary myopathies, and inflammatory muscle diseases. (See",
"      <a class=\"local\" href=\"#H11512155\">",
"       'Causes of rhabdomyolysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The causes of intravascular hemolysis include ABO-incompatible blood transfusions, glucose-6-phosphate dehydrogenase (G6PD) deficiency, poisonings; snake and insect bites, drug reactions, paroxysmal nocturnal hemoglobinuria (PNH), and malaria. (See",
"      <a class=\"local\" href=\"#H11512162\">",
"       'Causes of hemolysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical manifestations of heme-induced AKI include oliguria or anuria, red or brown urine and pigmented granular casts on urinalysis. Patients with rhabdomyolysis have increased plasma creatine kinase (CK). Patients with hemolysis have a reduced haptoglobin and an abnormal peripheral blood smear. An increased serum lactate dehydrogenase (LDH) may be seen in hemolysis and rhabdomyolysis. (See",
"      <a class=\"local\" href=\"#H11512176\">",
"       'Clinical manifestations'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/34/22058?source=see_link&amp;anchor=H4#H4\">",
"       \"Urinalysis in the diagnosis of kidney disease\", section on 'Red to brown urine'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The diagnosis of heme-induced AKI is suggested by oliguria in the setting of either known rhabdomyolysis or hemolysis, dipstick microhematuria in the absence of visible red cells by urine microscopy, and the presence of dark brown granular casts. A markedly elevated serum CK level is diagnostic of rhabdomyolysis. (See",
"      <a class=\"local\" href=\"#H11512254\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hemolysis is suggested by reddish discoloration of plasma and by an increased serum LDH. Hemolysis is confirmed by examination of the peripheral smear, increased reticulocyte percentage, a reduced or absent level of serum haptoglobin, and a positive Coombs test. (See",
"      <a class=\"local\" href=\"#H11512254\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link\">",
"       \"Approach to the diagnosis of hemolytic anemia in the adult\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/1\">",
"      Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996; 49:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/2\">",
"      Better OS, Stein JH. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med 1990; 322:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/3\">",
"      Heyman SN, Rosen S, Fuchs S, et al. Myoglobinuric acute renal failure in the rat: a role for medullary hypoperfusion, hypoxia, and tubular obstruction. J Am Soc Nephrol 1996; 7:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/4\">",
"      Holt S, Moore K. Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin. Exp Nephrol 2000; 8:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/5\">",
"      Zager RA, Burkhart KM, Conrad DS, Gmur DJ. Iron, heme oxygenase, and glutathione: effects on myohemoglobinuric proximal tubular injury. Kidney Int 1995; 48:1624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/6\">",
"      Olerud JE, Homer LD, Carroll HW. Incidence of acute exertional rhabdomyolysis. Serum myoglobin and enzyme levels as indicators of muscle injury. Arch Intern Med 1976; 136:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/7\">",
"      Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore) 2005; 84:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/8\">",
"      Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990; 30:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/9\">",
"      Mishra SK, Das BS. Malaria and acute kidney injury. Semin Nephrol 2008; 28:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/10\">",
"      Lau HK, Li CH, Lee AC. Acute massive haemolysis in children with glucose-6-phosphate dehydrogenase deficiency. Hong Kong Med J 2006; 12:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/11\">",
"      Jha V, Chugh KS. Community-acquired acute kidney injury in Asia. Semin Nephrol 2008; 28:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/12\">",
"      Anuradha S, Arora S, Mehrotra S, et al. Acute renal failure following para-phenylenediamine (PPD) poisoning: a case report and review. Ren Fail 2004; 26:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/13\">",
"      Kanjanabuch T, Sitprija V. Snakebite nephrotoxicity in Asia. Semin Nephrol 2008; 28:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/14\">",
"      Viraraghavan R, Chakravarty AG, Soreth J. Cefotetan-induced haemolytic anaemia. A review of 85 cases. Adverse Drug React Toxicol Rev 2002; 21:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/15\">",
"      Kapur G, Valentini RP, Mattoo TK, et al. Ceftriaxone induced hemolysis complicated by acute renal failure. Pediatr Blood Cancer 2008; 50:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/16\">",
"      Nair RK, Khaira A, Sharma A, et al. Spectrum of renal involvement in paroxysmal nocturnal hemoglobinuria: report of three cases and a brief review of the literature. Int Urol Nephrol 2008; 40:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/17\">",
"      Kirkizlar O, Kendir M, Karaali Z, et al. Acute renal failure in a patient with severe hemolysis. Int Urol Nephrol 2007; 39:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/18\">",
"      Brem AS. Insights Into Glucocorticoid-Associated Hypertension. Am J Kidney Dis 2001; 37:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/19\">",
"      Mate-Kole MO, Yeboah ED, Affram RK, Adu D. Blackwater fever and acute renal failure in expatriates in Africa. Ren Fail 1996; 18:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/20\">",
"      Pinho FM, Yu L, Burdmann EA. Snakebite-induced acute kidney injury in Latin America. Semin Nephrol 2008; 28:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/21\">",
"      Abdulkader RC, Barbaro KC, Barros EJ, Burdmann EA. Nephrotoxicity of insect and spider venoms in Latin America. Semin Nephrol 2008; 28:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/22\">",
"      Prakash J, Gupta A, Kumar O, et al. Acute renal failure in falciparum malaria--increasing prevalence in some areas of India--a need for awareness. Nephrol Dial Transplant 1996; 11:2414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/23\">",
"      Vermeulen Windsant IC, Snoeijs MG, Hanssen SJ, et al. Hemolysis is associated with acute kidney injury during major aortic surgery. Kidney Int 2010; 77:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/24\">",
"      Sauret JM, Marinides G, Wang GK. Rhabdomyolysis. Am Fam Physician 2002; 65:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/25\">",
"      Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine (Baltimore) 1982; 61:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/26\">",
"      Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med 1988; 148:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/27\">",
"      Sharp LS, Rozycki GS, Feliciano DV. Rhabdomyolysis and secondary renal failure in critically ill surgical patients. Am J Surg 2004; 188:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/28\">",
"      Centers for Disease Control and Prevention (CDC). Hemolysis associated with 25% human albumin diluted with sterile water--United States, 1994-1998. MMWR Morb Mortal Wkly Rep 1999; 48:157.",
"     </a>",
"    </li>",
"    <li>",
"     Fabris, A, Pellanda, et al. Rhabdomyolysis. In: Critical Care Nephrology, Ronco, C, Bellomo, R (Eds), Kluwer Academic Publishers, Amsterdam 1998. p.739.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/30\">",
"      Grossman RA, Hamilton RW, Morse BM, et al. Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med 1974; 291:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/31\">",
"      Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA 1980; 243:1909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/32\">",
"      Grover DS, Atta MG, Eustace JA, et al. Lack of clinical utility of urine myoglobin detection by microconcentrator ultrafiltration in the diagnosis of rhabdomyolysis. Nephrol Dial Transplant 2004; 19:2634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/33\">",
"      Huerta-Alard&iacute;n AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians. Crit Care 2005; 9:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/34\">",
"      Corwin HL, Schreiber MJ, Fang LS. Low fractional excretion of sodium. Occurrence with hemoglobinuric- and myoglobinuric-induced acute renal failure. Arch Intern Med 1984; 144:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/35\">",
"      Poels PJ, Gabre&euml;ls FJ. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg 1993; 95:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/36\">",
"      Mikkelsen TS, Toft P. Prognostic value, kinetics and effect of CVVHDF on serum of the myoglobin and creatine kinase in critically ill patients with rhabdomyolysis. Acta Anaesthesiol Scand 2005; 49:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/37\">",
"      de Meijer AR, Fikkers BG, de Keijzer MH, et al. Serum creatine kinase as predictor of clinical course in rhabdomyolysis: a 5-year intensive care survey. Intensive Care Med 2003; 29:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/38\">",
"      Hatamizadeh P, Najafi I, Vanholder R, et al. Epidemiologic aspects of the Bam earthquake in Iran: the nephrologic perspective. Am J Kidney Dis 2006; 47:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/39\">",
"      Veenstra J, Smit WM, Krediet RT, Arisz L. Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant 1994; 9:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/40\">",
"      Li SF, Zapata J, Tillem E. The prevalence of false-positive cardiac troponin I in ED patients with rhabdomyolysis. Am J Emerg Med 2005; 23:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/41\">",
"      Saenz AJ, Lee-Lewandrowski E, Wood MJ, et al. Measurement of a plasma stroke biomarker panel and cardiac troponin T in marathon runners before and after the 2005 Boston marathon. Am J Clin Pathol 2006; 126:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/42\">",
"      Lappalainen H, Tiula E, Uotila L, M&auml;ntt&auml;ri M. Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: implications for follow-up. Crit Care Med 2002; 30:2212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/43\">",
"      Lordon RE, Burton JR. Post-traumatic renal failure in military personnel in Southeast Asia. Experience at Clark USAF hospital, Republic of the Philippines. Am J Med 1972; 53:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/44\">",
"      STRAUSS MB. Acute renal insufficiency due to lower-nephron nephrosis. N Engl J Med 1948; 239:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/45\">",
"      Llach F, Felsenfeld AJ, Haussler MR. The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. Interactions of parathyroid hormone, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol. N Engl J Med 1981; 305:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/46\">",
"      Akmal M, Bishop JE, Telfer N, et al. Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure. J Clin Endocrinol Metab 1986; 63:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/47\">",
"      Lane JT, Boudreau RJ, Kinlaw WB. Disappearance of muscular calcium deposits during resolution of prolonged rhabdomyolysis-induced hypercalcemia. Am J Med 1990; 89:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/48\">",
"      Chao YW, Yang AH, Ng YY, Yang WC. Acute interstitial nephritis and pigmented tubulopathy in a patient after wasp stings. Am J Kidney Dis 2004; 43:e15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/49\">",
"      Knochel JP. Hypophosphatemia and rhabdomyolysis. Am J Med 1992; 92:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/50\">",
"      Oh MS. Does serum creatinine rise faster in rhabdomyolysis? Nephron 1993; 63:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/51\">",
"      Woodrow G, Brownjohn AM, Turney JH. The clinical and biochemical features of acute renal failure due to rhabdomyolysis. Ren Fail 1995; 17:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/52\">",
"      Lee S, Kim W, Park SK, et al. A case of acute renal failure, rhabdomyolysis and disseminated intravascular coagulation associated with severe exercise-induced hypernatremic dehydration. Clin Nephrol 2004; 62:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/53\">",
"      Bagley WH, Yang H, Shah KH. Rhabdomyolysis. Intern Emerg Med 2007; 2:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22632/abstract/54\">",
"      Gunst JJ, Langlois MR, Delanghe JR, et al. Serum creatine kinase activity is not a reliable marker for muscle damage in conditions associated with low extracellular glutathione concentration. Clin Chem 1998; 44:939.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14034 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-2BB6473422-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22632=[""].join("\n");
var outline_f22_6_22632=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11512261\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11512141\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11512148\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11512155\">",
"      Causes of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11512162\">",
"      Causes of hemolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11512169\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11512176\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11512183\">",
"      Urinalysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11512190\">",
"      Other laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11512198\">",
"      - Creatine kinase",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11512205\">",
"      - Potassium",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11512212\">",
"      - Calcium",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11512226\">",
"      - Phosphate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11512233\">",
"      - Creatinine-to-urea ratio",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11512240\">",
"      - Transaminases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11512247\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11512254\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11512261\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?25/13/25809?source=related_link\" title=\"calculator 1\">",
"      Calculator: Fractional excretion of sodium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?24/28/25025?source=related_link\" title=\"calculator 2\">",
"      Calculator: Fractional excretion of sodium (SI units)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=related_link\">",
"      Approach to the diagnosis of hemolytic anemia in the adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=related_link\">",
"      Clinical manifestations and diagnosis of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43833?source=related_link\">",
"      Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15369?source=related_link\">",
"      Crush-related acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/34/6697?source=related_link\">",
"      Extrinsic nonimmune hemolytic anemia due to systemic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/17/8472?source=related_link\">",
"      Fractional excretion of sodium, urea, and other molecules in acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21847?source=related_link\">",
"      Prevention and treatment of heme pigment-induced acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37766?source=related_link\">",
"      Transfusion-associated immune and non immune-mediated hemolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/54/17258?source=related_link\">",
"      Treatment and prevention of hyperkalemia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44632?source=related_link\">",
"      Treatment of hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/34/22058?source=related_link\">",
"      Urinalysis in the diagnosis of kidney disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_6_22633="Risks associated with epilepsy and pregnancy";
var content_f22_6_22633=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Risks associated with epilepsy and pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/6/22633/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/6/22633/contributors\">",
"     Steven C Schachter, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/6/22633/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/6/22633/contributors\">",
"     Timothy A Pedley, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/6/22633/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/6/22633/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/6/22633/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/6/22633/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over 90 percent of women with epilepsy have a normal pregnancy. This point should be emphasized to the patient who is likely to have many fears and anxieties regarding the risks. Nonetheless, there are a number of fetal and obstetrical complications associated with women with epilepsy. It is important for physicians and women with epilepsy to be aware of these as careful planning and management of pregnancy can increase the odds of a favorable outcome.",
"   </p>",
"   <p>",
"    There are a number of important issues to be addressed by the physician when a woman with epilepsy becomes pregnant; these include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Are antiepileptic drugs (AEDs) necessary?",
"     </li>",
"     <li>",
"      What effect do AEDs have on the fetus?",
"     </li>",
"     <li>",
"      What effect does maternal epilepsy have on the fetus?",
"     </li>",
"     <li>",
"      What effect does pregnancy have on seizures?",
"     </li>",
"     <li>",
"      How should the patient be managed during pregnancy and delivery?",
"     </li>",
"     <li>",
"      How should the patient be managed during the postpartum period?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will discuss the risks associated with epilepsy and pregnancy. The management of pregnancy and epilepsy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/16/15625?source=see_link\">",
"     \"Management of epilepsy and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OBSTETRICAL COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of obstetrical complications are reported to be more common in women with epilepsy; these range from mild to severe, and include a low birth weight, lower Apgar scores, preeclampsia, bleeding, placental abruption, and prematurity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]. However, the evidence associating many of these complications with epilepsy is limited and was considered inconclusive in a 2009 systematic review [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. At most, the risks of obstetrical complications were considered to be small. This was also the conclusion of a large population-based cohort study in Norway [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Perinatal mortality and miscarriage",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rates of stillbirth, neonatal death, and perinatal death vary widely and have been reported to be as high as two to three times greater in infants born to women with epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Absolute values are in general low but vary considerably among populations studied (1.3 to 14 percent for women with epilepsy compared with baseline values of 0.4 to 8 percent). This wide variability suggests that other factors beside epilepsy are likely to be more determinant in an individual's risk of perinatal mortality.",
"   </p>",
"   <p>",
"    The mechanism of this risk is not well understood. In one study, the investigators found an increased risk of spontaneous abortion for both fathers and mothers with epilepsy compared with same-sex siblings [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/11\">",
"     11",
"    </a>",
"    ]. Other studies have found that treated versus untreated epilepsy carried a higher risk of miscarriage or stillbirth; but treatment may have been a marker for more serious epilepsy rather than the cause of mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/12\">",
"     12",
"    </a>",
"    ]. In a large European registry, only 1 of 165 reported miscarriages or stillbirths was associated with seizures or status epilepticus (SE); two-thirds of these pregnancies were seizure free [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of perinatal mortality appears to be declining over time, and may be further minimized for women whose pregnancy and epilepsy are closely managed according to a recommended protocol [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/14-17\">",
"     14-17",
"    </a>",
"    ]. In one review, among 179 pregnancies in women with epilepsy in Finland between 1989 and 2000 that were managed according to a recommended protocol, there were no fetal deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/14\">",
"     14",
"    </a>",
"    ]. The baseline rate in this population was also low (0.4 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EFFECT OF ANTIEPILEPTIC DRUGS ON THE FETUS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Fetal and neonatal effects",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7523673\">",
"    <span class=\"h3\">",
"     Overview and risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is an increased risk of both major and minor malformations in fetuses exposed to the AEDs. The reported risk of major fetal malformations in women taking AEDs is 4 to 6 percent, compared with a population estimate of 2 to 3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/10,15,17-20\">",
"     10,15,17-20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common major congenital malformations associated with AEDs are neural tube, congenital heart and urinary tract defects, skeletal abnormalities, and cleft palate [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/10,21,22\">",
"     10,21,22",
"    </a>",
"    ]. The risk of certain dysmorphic features (generally considered minor malformations) associated with the administration of AEDs is less clear [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Many of these drugs appear to be implicated in dysmorphisms, such as hypoplasia of the nails and distal phalanges, hypertelorism, and the \"anticonvulsant face\" (broad or depressed nasal bridge, short nose with anteverted nostrils, long upper lip, maxillary hypoplasia) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/23,25\">",
"     23,25",
"    </a>",
"    ]. In a retrospective review of children born to mothers with epilepsy, 74 percent of children exposed to AEDs in utero were identified by a panel of expert dysmorphologists as having facial features that were either mildly, moderately, or obviously suggestive of fetal anticonvulsant syndrome; however, 61 percent of unexposed children also had these facial features, suggesting that these can be nonspecific [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. The term fetal anticonvulsant syndrome is often used to describe infants exposed to AEDs in utero who are born with congenital malformations. However, none of these malformations are specific to AED exposure.",
"   </p>",
"   <p>",
"    Some groups may be at higher risk than others:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The risk of fetal malformations is strongly influenced by AED therapy, in particular",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"       valproate",
"      </a>",
"      exposure [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/19,20,22\">",
"       19,20,22",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"       Phenytoin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/40/29321?source=see_link\">",
"       phenobarbital",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"       topiramate",
"      </a>",
"      have also been associated with higher baseline rates of fetal malformations [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/2,7,12,18,22,28-32\">",
"       2,7,12,18,22,28-32",
"      </a>",
"      ]. The risks associated with other AEDs are not yet certain.",
"     </li>",
"     <li>",
"      Polytherapy with more than one AED is a risk factor for fetal malformation as identified in a number of prospective, registry studies, with a risk of major malformation increasing to 6 to 8.6 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/18,20\">",
"       18,20",
"      </a>",
"      ]. Polytherapy with a regimen that includes",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"       valproate",
"      </a>",
"      represents a particularly high risk for fetal malformation [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A family history of birth defects, low folate levels, and a low maternal level of education have been identified as additional risk factors for fetal malformations, at least in some studies [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/18,19,22,31,34-37\">",
"       18,19,22,31,34-37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In addition to the specific AED used alone or in combination, the gestational timing of the exposure and the dose of AED used are also likely to be important. These have been best associated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"       valproate",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/19,22,32,37,38\">",
"       19,22,32,37,38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The mechanism for AED-induced teratogenicity has not been determined. One possibility is that some fetuses have low or deficient epoxide hydrolase activity that results in increased levels of teratogenic oxidative metabolites when they are exposed to AEDs [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/39\">",
"     39",
"    </a>",
"    ]. Another mechanism involves oxidative damage to DNA from free radical intermediates produced by prostaglandin H synthase bioactivation of AEDs [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/40\">",
"     40",
"    </a>",
"    ]. Deficiency of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    has also been implicated in teratogenicity associated with AEDs, which are folic acid antagonists.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Valproate",
"    </span>",
"    &nbsp;&mdash;&nbsp;One to 2 percent of fetuses exposed to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    in utero develop neural-tube like defects (spina bifida aperta, open lumbosacral myelocele), a 10- to 20-fold increase over the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/29,41,42\">",
"     29,41,42",
"    </a>",
"    ]. There also may be a pattern of major malformations consisting of meningomyelocele, cardiovascular, and urogenital malformations with minor craniofacial, skeletal, and genital anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/42\">",
"     42",
"    </a>",
"    ]. One retrospective review of children exposed to valproate in utero examined by expert dysmorphologists found that abnormal facial features were seen in more than 90 percent, compared with 61 percent of unexposed children and 48 to 79 percent of children exposed to other AEDs. Higher valproate doses are associated with more frequent and more severe dysmorphia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/22,26,27\">",
"     22,26,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    First trimester maternal exposure to valproic acid (VPA) increases the risk of major malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The North American AED Pregnancy Registry followed 323",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"       valproate",
"      </a>",
"      -exposed pregnancies to completion [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/43,44\">",
"       43,44",
"      </a>",
"      ]. The prevalence of major birth defects in offspring of women who received valproate monotherapy was 9.3 percent, as compared with 2.9 percent in offspring of women receiving other AEDs and 1.1 percent in an AED unexposed control group. Thus, the relative risk of major malformation in VPA-exposed women was 9.0 (95% CI 3.4-23.3). Increased dose of VPA was also associated with increased risk (OR = 3.7 for VPA &le;1500",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      versus OR=10.9 for VPA &gt;1500",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/19\">",
"       19",
"      </a>",
"      ], a finding also seen in other studies [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/22,37\">",
"       22,37",
"      </a>",
"      ]. The fact that valproate exposure, independent of the underlying epilepsy syndrome, was associated with malformation risk in this registry further implicates the role of the drug, rather than the underlying epilepsy, in the incidence of fetal malformations [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the Australian registry of AEDs in Pregnancy, 17 percent of 110 infants exposed to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"       valproate",
"      </a>",
"      had malformations, a higher incidence than for infants exposed to other AEDs alone or in combination (OR = 8.56; 95% CI 3.52-21.2) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/38\">",
"       38",
"      </a>",
"      ]. Valproate doses &le;1400 mg per day were associated with lower rates of malformations than higher doses (OR = 0.109; 95% CI 0.04-0.30). A similar incidence and dose effect for valproate on fetal malformations was reported in a registry comparing monotherapy AED regimens [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A case-control study using the European Surveillance of Congenital Anomalies database (registering a combined total of 98,075 major congenital malformations) found that VPA was associated with an increased risk for several congenital malformations [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/46\">",
"       46",
"      </a>",
"      ]. Compared with no AED use, adjusted odds ratios for specific malformations were: spina bifida (12.7), atrial septal defect (2.5), cleft palate (5.2), hypospadias (4.8), polydactyly (2.2), and craniosynostosis (6.8). Odds ratios were similarly elevated for the comparison of VPA use to other AED use.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In rare patients, neonatal coagulopathy, due to hypofibrinogenemia caused by VPA, has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Phenytoin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Orofacial clefts, cardiac malformations, and genitourinary defects are the major anomalies described with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/7,21,28,32,49,50\">",
"     7,21,28,32,49,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In utero exposure to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    has been associated with the development of neuroblastoma in several case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14585?source=see_link\">",
"     \"Epidemiology, pathogenesis, and pathology of neuroblastoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Phenobarbital",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malformations of the heart, orofacial, and urogenital structures occur with increased frequency with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/40/29321?source=see_link\">",
"     phenobarbital",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/7,21,49,50,52,53\">",
"     7,21,49,50,52,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Findings from the North American AED Pregnancy Registry found a 5.5 percent incidence of major malformations among 199 pregnancies associated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/40/29321?source=see_link\">",
"     phenobarbital",
"    </a>",
"    use, a rate that was somewhat higher than for unexposed pregnancies and for those exposed to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    . [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Carbamazepine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     Carbamazepine",
"    </a>",
"    has been associated with major malformations, in particular, spina bifida [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/7,42,54\">",
"     7,42,54",
"    </a>",
"    ]. As many as 0.9 percent of fetuses exposed in utero to carbamazepine have spina bifida aperta (a seven-fold increase) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/21,42,55,56\">",
"     21,42,55,56",
"    </a>",
"    ]. However, in the United Kingdom Epilepsy and Pregnancy Registry, compared with other AEDs, carbamazepine was associated with the lowest rate of major congenital malformations: 2.2 percent of 900 pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/20\">",
"     20",
"    </a>",
"    ]. The incidence of neural tube defects in carbamazepine-exposed pregnancies was 0.2 percent in this study. Similarly, in the North American AED pregnancy and in the EUROCAT Antiepileptic Study Database, the risk of fetal malformations associated with carbamazepine monotherapy was 2.9 percent and 3.3 percent respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/33,44,54\">",
"     33,44,54",
"    </a>",
"    ]. Another registry reported a 4.5 percent incidence of genitourinary malformations in infants born to mothers on carbamazepine monotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Lamotrigine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Of the newer AEDs,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    has been most studied:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Three registries have reported a 1.9 to 3.2 percent incidence of major malformations after first trimester exposure to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      monotherapy [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/20,33,44,57-60\">",
"       20,33,44,57-60",
"      </a>",
"      ]. This is similar to estimates from general population-based cohorts.",
"     </li>",
"     <li>",
"      The data regarding risk and dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      has been conflicting. The International Lamotrigine Pregnancy Registry found no effect of lamotrigine dose, up to 400",
"      <span class=\"nowrap\">",
"       mg/day,",
"      </span>",
"      on the incidence of major malformations [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/60,61\">",
"       60,61",
"      </a>",
"      ]. However, the United Kingdom Epilepsy and Pregnancy Registry did observe a dose-relationship and suggested that doses higher than 200 mg per day might present a risk similar to that of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"       valproate",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/20\">",
"       20",
"      </a>",
"      ]. In the EURAP Epilepsy and Pregnancy Registry, the incidence of fetal malformations with lamotrigine at any dose was low, but was significantly higher for patients taking 300mg or more each day than for patients taking lower doses (2.0 versus 4.5 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Data released from the manufacturer's pregnancy registry in January 2008 reported that the risk of major malformations after exposure to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      used in polytherapy with other AEDs, not including VPA, was similar to that of lamotrigine monotherapy, but was increased in those exposed to lamotrigine and VPA, (16 of 143 pregnancies, 11.2 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/58\">",
"       58",
"      </a>",
"      ]. These findings were similar in the final report of the International Lamotrigine Pregnancy registry [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A report from the North American AED Pregnancy Registry noted a higher than expected prevalence of cleft palate",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cleft lip in infants exposed to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      in the first trimester, of 8.9 per 1000 compared with the expected 0.7 to 2.5 per 1000 [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/62\">",
"       62",
"      </a>",
"      ]. However, a population-based case control study derived from a European congenital anomaly register found that lamotrigine monotherapy did not specifically increase the risk of isolated orofacial clefts relative to other malformations [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/63\">",
"       63",
"      </a>",
"      ]. This study was not designed to study whether lamotrigine was associated with a generalized risk of malformations, and therefore could not determine an association.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26477904\">",
"    <span class=\"h3\">",
"     Topiramate",
"    </span>",
"    &nbsp;&mdash;&nbsp;In March 2011, the FDA issued a safety announcement regarding the incidence of oral clefts in infants whose mothers were exposed to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"     topiramate",
"    </a>",
"    in pregnancy, citing data from the North American AED Pregnancy registry and updated information from the United Kingdom Epilepsy and Pregnancy registry [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/64\">",
"     64",
"    </a>",
"    ]. In the former study, a 1.4 percent prevalence of oral clefts in topiramate-exposed infants was associated with a 21.3 relative risk (95% CI: 7.9 to 57.1) compared with a background population of untreated women [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/44\">",
"     44",
"    </a>",
"    ]. In the United Kingdom population, the 3.2 percent prevalence of oral clefts in newborns exposed to topiramate was 16 times higher than their background population. Across multiple studies to date, the estimated absolute risk of oral clefts in a topiramate-exposed pregnancy has ranged from 5 to 29 per 1000 births, compared to an expected unexposed risk in the background population of 1 to 2 per 1000 births [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/44,59,65,66\">",
"     44,59,65,66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Other newer AEDs",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is limited human information on the fetal risks of the newer AEDs (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/31/25079?source=see_link\">",
"     felbamate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/22/26982?source=see_link\">",
"     tiagabine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/52/43847?source=see_link\">",
"     levetiracetam",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/31/16887?source=see_link\">",
"     pregabalin",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a registry-based study in Denmark, major birth defects were detected in 11 of 393 infants exposed to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/25/40344?source=see_link\">",
"       oxcarbazepine",
"      </a>",
"      , a rate that was not significantly higher than in nonexposed infants [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/59\">",
"       59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/52/43847?source=see_link\">",
"       Levetiracetam",
"      </a>",
"      use in pregnancy was documented in the United Kingdom Epilepsy and Pregnancy registry in 117 exposed pregnancies [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/67\">",
"       67",
"      </a>",
"      ]. A major congenital malformation occurred in three; all of these were in patients on polytherapy. In the North American AED Pregnancy Registry, a risk of major malformations of 2.4 percent among levetiracetam-exposed pregnancies was not significantly different from controls [",
"      <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While animal and other preliminary data are reassuring [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/68\">",
"     68",
"    </a>",
"    ], patients should be counseled that the actual risks are largely unknown at this time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Long-term effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is accumulating evidence from observational studies that anticonvulsant treatment during pregnancy may have deleterious effects on the cognitive and neurologic function of the offspring that may manifest later in life [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/10,69-75\">",
"     10,69-75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     Valproate",
"    </a>",
"    is the most strongly associated with these adverse outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/7,26,27,76-79\">",
"     7,26,27,76-79",
"    </a>",
"    ]. A prospective study of 309 children who had been exposed to AEDs in utero found that at age three years, children exposed to valproate had IQ scores that were on average six to nine points lower than those exposed to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/80\">",
"     80",
"    </a>",
"    ]. These findings persisted at 4.5 years [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/81\">",
"     81",
"    </a>",
"    ]. Further support for this association are the findings that the relationship between IQ score and valproate exposure was dose related, and that children's IQ scores were related to maternal IQ scores in all exposure groups except for valproate. Another prospective blinded study of 182 children of mothers with epilepsy and 141 controls found significantly lower verbal intelligence associated with exposure to valproate and AED polytherapy but not to carbamazepine monotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/82\">",
"     82",
"    </a>",
"    ]. In another registry-based study, 102 school-aged children exposed to valproate in utero had lower than mean average language test scores on blinded assessments [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/83\">",
"     83",
"    </a>",
"    ]. Similarly, in another prospective study of 172 infants (mean age of 15 months), in utero exposure to valproate monotherapy was associated with lower mental and motor developmental quotients compared with carbamazepine monotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/84\">",
"     84",
"    </a>",
"    ]. Finally, the Liverpool and Manchester Neurodevelopment group reported that 4 of 64 children (6.3 percent) exposed to valproate in utero developed autism spectrum disorder, a 10-fold higher rate than in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reports from other studies also implicate",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/14/30952?source=see_link\">",
"     primidone",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/40/29321?source=see_link\">",
"     phenobarbital",
"    </a>",
"    exposures with impaired cognitive performance later in life [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/7,75,81,86-88\">",
"     7,75,81,86-88",
"    </a>",
"    ]. Polytherapy may present a higher risk than monotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/7,74,86\">",
"     7,74,86",
"    </a>",
"    ], and verbal abilities may be particularly affected [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/81,89\">",
"     81,89",
"    </a>",
"    ]. Some studies find that the risk of cognitive impairments is highest in those who also have one or more of the congenital malformations described above [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/26,27,90\">",
"     26,27,90",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/16/15625?source=see_link&amp;anchor=H6#H6\">",
"     \"Management of epilepsy and pregnancy\", section on 'Choice of antiepileptic drug'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     EFFECT OF EPILEPSY ON THE FETUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to concerns about fetal exposure to AEDs, there are risks to the fetus from maternal seizures and maternal epilepsy. As mentioned above, a history of epilepsy alone does not appear to increase the risk of fetal malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/18\">",
"     18",
"    </a>",
"    ]. However, this study did not directly assess the risk associated with maternal seizures during pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Risk to the fetus of maternal seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few studies have been performed on the direct effects of maternal seizures on the fetus. Fetal hypoxia may occur as a result of decreased placental blood flow or postictal apnea; but no information is available on the number or length of seizures that may jeopardize the fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/91,92\">",
"     91,92",
"    </a>",
"    ]. One report of fetal heart rate monitoring during a maternal generalized tonic-clonic seizure lasting 2.5 minutes revealed significant fetal heart rate deceleration lasting up to 30 minutes after the seizure [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/91\">",
"     91",
"    </a>",
"    ]. While nonconvulsive seizures are believed to be less dangerous, another case report has documented significant fetal bradycardia during a one-minute, complex partial seizure [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional risks of maternal seizures include injury to the fetus, abruption, or miscarriage due to maternal trauma sustained during a seizure.",
"   </p>",
"   <p>",
"    One prospective study found no association between first trimester seizures and major fetal malformations, but the confidence intervals were wide (odds ratio 0.6, 95% CI 0.1-2.9) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/31\">",
"     31",
"    </a>",
"    ]. Another cohort study reported that the occurrence of one or more major antepartum seizures in 63 epileptic women did not significantly increase the rate of antepartum complications, congenital anomalies, stillbirth, fetal growth restriction, or microcephaly compared with epileptic women without antepartum seizures; however, long-term outcome data were not provided [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/3\">",
"     3",
"    </a>",
"    ]. Finally, in a population-based data set in Taiwan, epileptic seizures during pregnancy were marginally associated with small for gestational age infants compared with women with epilepsy who did not suffer seizures during pregnancy (HR 1.37; 95% CI:1.01-1.84) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Even for SE, the risks to the fetus are unclear. In a large European registry of 1956 pregnancies in 1882 women with epilepsy, SE occurred in 1.8 percent, one-third of which were convulsive type [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/13\">",
"     13",
"    </a>",
"    ]. Only one case of SE was associated with stillbirth; the remaining cases were not clearly associated with fetal or maternal complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Inheritance of epilepsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epilepsy affects approximately 0.5 to 1 percent of the general population; the risk of a seizure disorder is greater among the children of mothers with epilepsy.",
"   </p>",
"   <p>",
"    In one study of 687 children of parents with epilepsy, the cumulative incidence of unprovoked seizures up to age 25 was about four-fold higher in the offspring of affected mothers than in the offspring of affected fathers (9 versus 2 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/94\">",
"     94",
"    </a>",
"    ]. Neither a paternal seizure disorder nor maternal seizures nor AED use during pregnancy led to increased susceptibility to epilepsy in the offspring in this study [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/94,95\">",
"     94,95",
"    </a>",
"    ]. In another series, a history of spontaneous abortion in a mother with epilepsy was associated with an increased risk of epilepsy in her live-born children (rate ratio 4.6; 95% CI:2.3-9.0) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/96\">",
"     96",
"    </a>",
"    ]. Idiopathic epilepsy carries a higher risk of inheritance than symptomatic epilepsy; offspring typically inherit the seizure type of the parent but tend to have an earlier age of onset [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     EFFECT OF PREGNANCY ON SEIZURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of seizures does not increase during pregnancy in the majority of women with epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/2,6,17,98,99\">",
"     2,6,17,98,99",
"    </a>",
"    ]. A large European registry of epilepsy in pregnancy confirmed the statistics related to seizure control in pregnancy which had been previously reported in an aggregate of smaller studies [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/13\">",
"     13",
"    </a>",
"    ]. Among 1956 pregnancies in 1882 women with epilepsy, seizure frequency and AED treatment remained unchanged in 62 to 64 percent; 58 percent were seizure free during pregnancy. Risk factors for seizures during pregnancy included localization-related (focal) epilepsy as compared with generalized epilepsy and AED polytherapy. SE occurred in 1.8 percent, one-third of which were convulsive type. No risk factors for SE were identified. In another cohort of 1297 pregnancies in women with epilepsy, seizures during the month prior to pregnancy was the most important predictor of seizures during pregnancy; other independent predictors included partial (versus generalized) seizures and polytherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/100\">",
"     100",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/1/23578?source=see_link\">",
"     \"Localization-related (partial) epilepsy: Causes and clinical features\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many women who experience increased seizure frequency are sleep deprived or noncompliant because of concerns about the effects of the medication on the developing fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/101,102\">",
"     101,102",
"    </a>",
"    ]. Altered AED pharmacokinetics may also contribute to change in seizure frequency during pregnancy (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/16/15625?source=see_link&amp;anchor=H11#H11\">",
"     \"Management of epilepsy and pregnancy\", section on 'Drug levels and dose adjustment'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Seizures rarely occur at the time of delivery, in only 3.5 percent of the European cohort [",
"    <a class=\"abstract\" href=\"UTD.htm?22/6/22633/abstract/13\">",
"     13",
"    </a>",
"    ]. Labor and delivery are not usually associated with increased complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/5/30802?source=see_link\">",
"       \"Patient information: Epilepsy and pregnancy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the majority of women with epilepsy will have uncomplicated pregnancies, there is a higher risk of certain complications in this population.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A two- to three-fold risk of perinatal mortality has been reported in infants born to women with epilepsy compared with controls. (Population values vary widely, however). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Perinatal mortality and miscarriage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Both major and minor malformations are more common in fetuses exposed to antiepileptic drugs (AEDs) in utero compared with offspring of untreated women with epilepsy and women without epilepsy. The overall risk of major malformations is 4 to 6 percent;",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"       valproate",
"      </a>",
"      is a major contributor to this risk. Polypharmacy and higher AED dose increase the risk. The timing (early versus late in gestation) and dose of exposure are also likely to be important. Valproate should be avoided in pregnancy, if possible. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Fetal and neonatal effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is increasing evidence that AED exposure in utero may be associated with impaired cognitive development. The evidence for this association is strongest with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"       valproate",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Long-term effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Seizures, particularly convulsive seizures, are believed to be harmful to the fetus. Fetal bradycardia has been documented during maternal seizures. However, studies documenting the risk that seizures pose to the fetus are lacking. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Risk to the fetus of maternal seizures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most women will have no alteration of their seizure pattern during pregnancy, especially if noncompliance and sleep deprivation are minimized. Altered pharmacokinetics of AEDs during pregnancy may also contribute to increased seizure frequency in a small number of women (see",
"      <a class=\"local\" href=\"#H16\">",
"       'Effect of pregnancy on seizures'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Risks associated with pregnancy and epilepsy can be minimized by preconception planning and careful management during pregnancy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/16/15625?source=see_link\">",
"       \"Management of epilepsy and pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/1\">",
"      Yerby M, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia 1985; 26:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/2\">",
"      Tanganelli P, Regesta G. Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study. Neurology 1992; 42:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/3\">",
"      Richmond JR, Krishnamoorthy P, Andermann E, Benjamin A. Epilepsy and pregnancy: an obstetric perspective. Am J Obstet Gynecol 2004; 190:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/4\">",
"      Veiby G, Daltveit AK, Engelsen BA, Gilhus NE. Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia 2009; 50:2130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/5\">",
"      Borthen I, Eide MG, Daltveit AK, Gilhus NE. Obstetric outcome in women with epilepsy: a hospital-based, retrospective study. BJOG 2011; 118:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/6\">",
"      Harden CL, Hopp J, Ting TY, et al. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009; 73:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/7\">",
"      Harden CL, Meador KJ, Pennell PB, et al. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009; 73:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/8\">",
"      Borthen I, Eide MG, Veiby G, et al. Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG 2009; 116:1736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/9\">",
"      Yerby MS. Epilepsy and pregnancy. New issues for an old disorder. Neurol Clin 1993; 11:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/10\">",
"      Meador KJ, Pennell PB, Harden CL, et al. Pregnancy registries in epilepsy: a consensus statement on health outcomes. Neurology 2008; 71:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/11\">",
"      Schupf N, Ottman R. Reproduction among individuals with idiopathic/cryptogenic epilepsy: risk factors for spontaneous abortion. Epilepsia 1997; 38:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/12\">",
"      Nakane Y, Okuma T, Takahashi R, et al. Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia 1980; 21:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/13\">",
"      EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006; 66:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/14\">",
"      Viinikainen K, Heinonen S, Eriksson K, K&auml;lvi&auml;inen R. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia 2006; 47:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/15\">",
"      Bassi V, Yerby MS, Devinsky O. Epilepsy. Adv Neurol 2002; 90:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/16\">",
"      Olafsson E, Hallgrimsson JT, Hauser WA, et al. Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 1998; 39:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/17\">",
"      Sabers A, aRogvi-Hansen B, Dam M, et al. Pregnancy and epilepsy: a retrospective study of 151 pregnancies. Acta Neurol Scand 1998; 97:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/18\">",
"      Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001; 344:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/19\">",
"      Artama M, Auvinen A, Raudaskoski T, et al. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 2005; 64:1874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/20\">",
"      Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006; 77:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/21\">",
"      Hern&aacute;ndez-D&iacute;az S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343:1608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/22\">",
"      Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011; 10:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/23\">",
"      Gaily E, Granstr&ouml;m ML. Minor anomalies in children of mothers with epilepsy. Neurology 1992; 42:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/24\">",
"      Yerby MS, Leavitt A, Erickson DM, et al. Antiepileptics and the development of congenital anomalies. Neurology 1992; 42:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/25\">",
"      Holmes LB, Harvey EA, Brown KS, et al. Anticonvulsant teratogenesis: I. A study design for newborn infants. Teratology 1994; 49:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/26\">",
"      Kini U, Adab N, Vinten J, et al. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed 2006; 91:F90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/27\">",
"      Perucca E, Tomson T. Prenatal exposure to antiepileptic drugs. Lancet 2006; 367:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/28\">",
"      Annegers JF, Hauser WA, Elveback LR, et al. Congenital malformations and seizure disorders in the offspring of parents with epilepsy. Int J Epidemiol 1978; 7:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/29\">",
"      Koch S, L&ouml;sche G, Jager-Rom&auml;n E, et al. Major and minor birth malformations and antiepileptic drugs. Neurology 1992; 42:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/30\">",
"      Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies. Neurology 2001; 57:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/31\">",
"      Kaaja E, Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology 2003; 60:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/32\">",
"      Meador KJ, Baker GA, Finnell RH, et al. In utero antiepileptic drug exposure: fetal death and malformations. Neurology 2006; 67:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/33\">",
"      Holmes LB, Mittendorf R, Shen A, et al. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch Neurol 2011; 68:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/34\">",
"      Lindhout D, H&ouml;ppener RJ, Meinardi H. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 1984; 25:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/35\">",
"      Kaneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999; 33:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/36\">",
"      Samr&eacute;n EB, van Duijn CM, Koch S, et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997; 38:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/37\">",
"      Samr&eacute;n EB, van Duijn CM, Christiaens GC, et al. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999; 46:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/38\">",
"      Vajda FJ, Eadie MJ. Maternal valproate dosage and foetal malformations. Acta Neurol Scand 2005; 112:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/39\">",
"      Finnell RH, Buehler BA, Kerr BM, et al. Clinical and experimental studies linking oxidative metabolism to phenytoin-induced teratogenesis. Neurology 1992; 42:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/40\">",
"      Parman T, Chen G, Wells PG. Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochemical product analysis. J Biol Chem 1998; 273:25079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/41\">",
"      Lindhout D, Omtzigt JG, Cornel MC. Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology 1992; 42:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/42\">",
"      Lindhout D, Schmidt D. In utero exposure to valproate and neural-tube defects. Lancet 1986; 2:1932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/43\">",
"      Wyszynski DF, Nambisan M, Surve T, et al. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005; 64:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/44\">",
"      Hern&aacute;ndez-D&iacute;az S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012; 78:1692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/45\">",
"      Bromfield EB, Dworetzky BA, Wyszynski DF, et al. Valproate teratogenicity and epilepsy syndrome. Epilepsia 2008; 49:2122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/46\">",
"      Jentink J, Loane MA, Dolk H, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 2010; 362:2185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/47\">",
"      Bavoux F, Fournier-Perhilou AI, Wood C, et al. Neonatal fibrinogen depletion caused by sodium valproate. Ann Pharmacother 1994; 28:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/48\">",
"      Majer RV, Green PJ. Neonatal afibrinogenaemia due to sodium valproate. Lancet 1987; 2:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/49\">",
"      Lindhout D, Meinardi H, Meijer JW, Nau H. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology 1992; 42:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/50\">",
"      Kaneko S, Otani K, Kondo T, et al. Malformation in infants of mothers with epilepsy receiving antiepileptic drugs. Neurology 1992; 42:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/51\">",
"      Satg&eacute; D, Sasco AJ, Little J. Antenatal therapeutic drug exposure and fetal/neonatal tumours: review of 89 cases. Paediatr Perinat Epidemiol 1998; 12:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/52\">",
"      Dravet C, Julian C, Legras C, et al. Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. Neurology 1992; 42:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/53\">",
"      Holmes LB, Wyszynski DF, Lieberman E. The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 2004; 61:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/54\">",
"      Jentink J, Dolk H, Loane MA, et al. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. BMJ 2010; 341:c6581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/55\">",
"      Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991; 324:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/56\">",
"      Hern&aacute;ndez-D&iacute;az S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 2001; 153:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/57\">",
"      Cunnington M, Tennis P, International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Lamotrigine and the risk of malformations in pregnancy. Neurology 2005; 64:955.",
"     </a>",
"    </li>",
"    <li>",
"     Glaxo SmithKline. The Lamotrigine Pregnancy registry. Interim report: 1 September 1992 through 30 September 2008; Issued January 2008. file://pregnancyregistry.gsk.com/lamotrigine.html (Accessed on March 31, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/59\">",
"      M&oslash;lgaard-Nielsen D, Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA 2011; 305:1996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/60\">",
"      Cunnington MC, Weil JG, Messenheimer JA, et al. Final results from 18 years of the International Lamotrigine Pregnancy Registry. Neurology 2011; 76:1817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/61\">",
"      Cunnington M, Ferber S, Quartey G, International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia 2007; 48:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/62\">",
"      Holmes LB, Baldwin EJ, Smith CR, et al. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 2008; 70:2152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/63\">",
"      Dolk H, Jentink J, Loane M, et al. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology 2008; 71:714.",
"     </a>",
"    </li>",
"    <li>",
"     FDA Drug Safety Communication: Risk of oral clefts in children born to mothers taking Topamax (topiramate). file://www.fda.gov/Drugs/DrugSafety/ucm245085.htm; U.S. Food and Drug administration, 2011.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/65\">",
"      Margulis AV, Mitchell AA, Gilboa SM, et al. Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol 2012; 207:405.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/66\">",
"      Hunt S, Russell A, Smithson WH, et al. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2008; 71:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/67\">",
"      Hunt S, Craig J, Russell A, et al. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2006; 67:1876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/68\">",
"      Morrell MJ. The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy, and fetal outcome. Epilepsia 1996; 37 Suppl 6:S34.",
"     </a>",
"    </li>",
"    <li>",
"     Hill RM, Vernaius WM, Retting GM, et al. Relationship of antiepileptic drug exposure of the infant and developmental potential. In: Epilepsy, pregnancy, and the child, Janz D, Dam M, Richens A (Eds), Raven, New York 1982.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/70\">",
"      Gaily E, Kantola-Sorsa E, Granstr&ouml;m ML. Specific cognitive dysfunction in children with epileptic mothers. Dev Med Child Neurol 1990; 32:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/71\">",
"      Thomas SV, Sukumaran S, Lukose N, et al. Intellectual and language functions in children of mothers with epilepsy. Epilepsia 2007; 48:2234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/72\">",
"      Vinten J, Bromley RL, Taylor J, et al. The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy Behav 2009; 14:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/73\">",
"      Oyen N, Vollset SE, Eide MG, et al. Maternal epilepsy and offsprings' adult intelligence: a population-based study from Norway. Epilepsia 2007; 48:1731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/74\">",
"      Forsberg L, Wide K, K&auml;ll&eacute;n B. School performance at age 16 in children exposed to antiepileptic drugs in utero--a population-based study. Epilepsia 2011; 52:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/75\">",
"      Cummings C, Stewart M, Stevenson M, et al. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 2011; 96:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/76\">",
"      Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001; 70:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/77\">",
"      Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004; 75:1575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/78\">",
"      McVearry KM, Gaillard WD, VanMeter J, Meador KJ. A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy. Epilepsy Behav 2009; 16:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/79\">",
"      Bromley RL, Mawer G, Love J, et al. Early cognitive development in children born to women with epilepsy: a prospective report. Epilepsia 2010; 51:2058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/80\">",
"      Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009; 360:1597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/81\">",
"      Meador KJ, Baker GA, Browning N, et al. Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology 2012; 78:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/82\">",
"      Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004; 62:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/83\">",
"      Nadebaum C, Anderson VA, Vajda F, et al. Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology 2011; 76:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/84\">",
"      Thomas SV, Ajaykumar B, Sindhu K, et al. Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav 2008; 13:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/85\">",
"      Bromley RL, Mawer G, Clayton-Smith J, et al. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008; 71:1923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/86\">",
"      Koch S, Titze K, Zimmermann RB, et al. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia 1999; 40:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/87\">",
"      Reinisch JM, Sanders SA, Mortensen EL, Rubin DB. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 1995; 274:1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/88\">",
"      Thorp JA, O'Connor M, Jones AM, et al. Does perinatal phenobarbital exposure affect developmental outcome at age 2? Am J Perinatol 1999; 16:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/89\">",
"      Meador KJ, Baker GA, Browning N, et al. Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain 2011; 134:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/90\">",
"      Holmes LB, Coull BA, Dorfman J, Rosenberger PB. The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs. J Pediatr 2005; 146:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/91\">",
"      Teramo K, Hiilesmaa V, Bardy A, Saarikoski S. Fetal heart rate during a maternal grand mal epileptic seizure. J Perinat Med 1979; 7:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/92\">",
"      Nei M, Daly S, Liporace J. A maternal complex partial seizure in labor can affect fetal heart rate. Neurology 1998; 51:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/93\">",
"      Chen YH, Chiou HY, Lin HC, Lin HL. Affect of seizures during gestation on pregnancy outcomes in women with epilepsy. Arch Neurol 2009; 66:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/94\">",
"      Ottman R, Annegers JF, Hauser WA, Kurland LT. Higher risk of seizures in offspring of mothers than of fathers with epilepsy. Am J Hum Genet 1988; 43:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/95\">",
"      Holmes GL, Weber DA. Effect of seizures during pregnancy on seizure susceptibility in offspring. Epilepsia 1985; 26:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/96\">",
"      Schupf N, Ottman R. Risk of epilepsy in offspring of affected women: association with maternal spontaneous abortion. Neurology 2001; 57:1642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/97\">",
"      Tsuboi T, Endo S. Incidence of seizures and EEG abnormalities among offspring of epileptic patients. Hum Genet 1977; 36:173.",
"     </a>",
"    </li>",
"    <li>",
"     Schmidt D. The effects of pregnancy on the natural history of epilepsy: Review of the literature. In: Epilepsy, Pregnancy and the Child, Janz D, Bossi L, Dam, M, et al (Eds), Raven, New York 1982. p.3.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/99\">",
"      Vajda FJ, Hitchcock A, Graham J, et al. Seizure control in antiepileptic drug-treated pregnancy. Epilepsia 2008; 49:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/100\">",
"      Thomas SV, Syam U, Devi JS. Predictors of seizures during pregnancy in women with epilepsy. Epilepsia 2012; 53:e85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/101\">",
"      Schmidt D, Canger R, Avanzini G, et al. Change of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiatry 1983; 46:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/6/22633/abstract/102\">",
"      Otani K. Risk factors for the increased seizure frequency during pregnancy and puerperium. Folia Psychiatr Neurol Jpn 1985; 39:33.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2218 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.66.252.144-C3286EAA3D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22633=[""].join("\n");
var outline_f22_6_22633=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OBSTETRICAL COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Perinatal mortality and miscarriage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EFFECT OF ANTIEPILEPTIC DRUGS ON THE FETUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Fetal and neonatal effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7523673\">",
"      - Overview and risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Valproate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Phenytoin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Phenobarbital",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Carbamazepine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Lamotrigine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26477904\">",
"      - Topiramate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Other newer AEDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Long-term effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      EFFECT OF EPILEPSY ON THE FETUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Risk to the fetus of maternal seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Inheritance of epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      EFFECT OF PREGNANCY ON SEIZURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14585?source=related_link\">",
"      Epidemiology, pathogenesis, and pathology of neuroblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/1/23578?source=related_link\">",
"      Localization-related (partial) epilepsy: Causes and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/16/15625?source=related_link\">",
"      Management of epilepsy and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/5/30802?source=related_link\">",
"      Patient information: Epilepsy and pregnancy (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_6_22634="Clue cell";
var content_f22_6_22634=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F52425%7EPC%2F73248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F52425%7EPC%2F73248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Clue cells",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 430px; height: 515px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Wet mount showing characteristic clue cells. Note that the epithelial cells are so heavily covered by bacteria as to obscure the margins.",
"    <br>",
"     (B) A clue cell. The vaginal epithelial cell on the right has shaggy borders obscured by coccobacilli (1003 magnification). The more normal appearing epithelial cell on the left has sharper borders.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      (A) Reproduced with permission from: Sweet RL, Gibbs RS. Atlas of Infectious Diseases of the Female Genital Tract. Philadelphia: Lippincott Williams &amp; Wilkins, 2005. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"      <br>",
"       (B) Reproduced with permission from: Fleisher GR, MD, Ludwig S, MD, Baskin MN, MD. Atlas of Pediatric Emergency Medicine. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"      </br>",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Clue cells",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of clue cells observed in a patient with bacterial vaginosis. Note the obliteration of each epithelial cell margin by adherent G. vaginalis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jack D Sobel, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22634=[""].join("\n");
var outline_f22_6_22634=null;
var title_f22_6_22635="Comparison of modalities";
var content_f22_6_22635=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Comparison of argon plasma coagulation, electrocautery, and cryotherapy via flexible bronchoscopy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Argon plasma coagulation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Electrocautery",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cryotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Immediate effect",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemoptysis control",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fire risk",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Foreign body removal",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mucous plug removal",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Effect on bronchial wall",
"       </td>",
"       <td>",
"        Scar",
"       </td>",
"       <td>",
"        <p>",
"         Scar",
"        </p>",
"        <p>",
"         Stricture",
"        </p>",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22635=[""].join("\n");
var outline_f22_6_22635=null;
var title_f22_6_22636="Recommendations to cardiopulmonary patients who fly";
var content_f22_6_22636=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52930&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52930&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    General recommendations to cardiopulmonary patients traveling by air",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        1. Allow extra time at airports and use porter services to avoid anxiety of and stress of hurried departures, transfers, and long walks with baggage.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Preboard if extra time or assistance is needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Carry on sufficient supply of medications for entire trip. Bring a fresh supply of sublingual nitroglycerin if applicable. Carry medications in carry-on baggage.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Bring a list of medications and prescriptions, kept separately from the medications themselves.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Take medications on schedule or adjust drug regimen when travel requires crossing multiple time zones.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. Carry a copy of most recent electrocardiogram (ECG), with and without pacemaker activation, and a pacemaker or defibrillator card, if applicable.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7. Request special meals (low salt, low cholesterol).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8. Avoid placing baggage in the space under the seat in front if that reduces the ability to move the legs. Flying first class or better designed aircrafts seats are considerations.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        9. Exercise legs at regular intervals while seated to improve venous flow, eg, strong alternating stretching and flexing of the feet.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10. Change position frequently and do not sleep in cramped position.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        11. Walk in cabin aisle every hour.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        12. Avoid hypnotic drugs, because veins can be damaged by unrecognized compression. Sleep also promotes muscular relaxation, which can lead to stasis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        13. Drink adequate fluids before and during the flight. Alcohol should be avoided on long trips due to diuretic and vasodilating effects.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        14. Consider elastic support stocking in patients with mild deep vein thromboembolism (DVT) risk.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        15. Consider low-dose aspirin, warfarin, or subcutaneous heparin before boarding in patients with moderate DVT risk.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        16. Consider full oral anticoagulation or low molecular weight heparin in patients with high DVT risk.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        17. Consider purchasing medical evacuation insurance if health insurance does not cover medical evacuation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;18. Carry a letter from caregiver(s) explaining condition, medications, allergies, and devices (such as pacemaker or implantable cardioverter defibrillator).",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Gong H. Cardiologica 1995; 40:477.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22636=[""].join("\n");
var outline_f22_6_22636=null;
var title_f22_6_22637="Imaging options for vomiting infant";
var content_f22_6_22637=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73955&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73955&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Appropriateness of various imaging options in infants 0 to 3 months with vomiting",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Radiologic procedure",
"       </td>",
"       <td class=\"subtitle1\">",
"        Rating",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"       <td class=\"subtitle1\">",
"        RRL*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Variant 1: Bilious vomiting in neonate up to 1 week old",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        X-ray abdomen",
"       </td>",
"       <td class=\"centered\">",
"        9",
"       </td>",
"       <td>",
"        Initial x-ray will help determine further workup strategy",
"       </td>",
"       <td align=\"center\">",
"        +++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        X-ray upper GI series",
"       </td>",
"       <td class=\"centered\">",
"        8",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td align=\"center\">",
"        +++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        X-ray contrast enema",
"       </td>",
"       <td class=\"centered\">",
"        7",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td align=\"center\">",
"        ++++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Variant 2: Bilious vomiting in infant 1 week to 3 months old",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        X-ray upper GI series",
"       </td>",
"       <td class=\"centered\">",
"        9",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td align=\"center\">",
"        +++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        X-ray abdomen",
"       </td>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td align=\"center\">",
"        +++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        US abdomen (UGI tract)",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td align=\"center\">",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tc-99m sulfur colloid reflux scintigraphy",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td align=\"center\">",
"        +++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Variant 3: Intermittent nonbilious vomiting since birth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        X-ray upper GI series",
"       </td>",
"       <td class=\"centered\">",
"        6",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td align=\"center\">",
"        +++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        US abdomen (UGI tract)",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td align=\"center\">",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tc-99m sulfur colloid reflux scintigraphy",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td>",
"        Seldom indicated for most patient evaluations, buy may provide useful information about gastric emptying and GER in select patients if other testing proves unrevealing",
"       </td>",
"       <td align=\"center\">",
"        +++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        X-ray abdomen",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td align=\"center\">",
"        +++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Variant 4: New onset projectile nonbilious vomiting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        US abdomen (UGI tract)",
"       </td>",
"       <td class=\"centered\">",
"        9",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td align=\"center\">",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        X-ray upper GI series",
"       </td>",
"       <td class=\"centered\">",
"        6",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td align=\"center\">",
"        +++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        X-ray abdomen",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td align=\"center\">",
"        +++",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Tc-99m sulfur colloid reflux scintigraphy",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td align=\"center\">",
"        +++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Rating scale: 1, 2, 3 usually not appropriate; 4, 5, 6 may be appropriate; 7, 8, 9 usually appropriate",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Relative radiation level. +++ denotes a Pediatric effective dose estimate range from 0.3 to 3 mSv. ++++ denotes a range from 3 to 10 mSv.",
"    </div>",
"    <div class=\"reference\">",
"     Bulas D, McGrane SL, Coley BD et al. Expert panel on pediatric imaging. ACR appropriateness criteria vomiting in infants up to 3 months of age. Available at:",
"     <a href=\"file://www.guideline.gov/content.aspx?id=32619\">",
"      file://www.guideline.gov/content.aspx?id=32619",
"     </a>",
"     (accessed 1/23/11). Reprinted with permission of the American College of Radiology. No other representation of this document is authorized without express, written permission from the American College of Radiology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22637=[""].join("\n");
var outline_f22_6_22637=null;
var title_f22_6_22638="Skin tag";
var content_f22_6_22638=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F70871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F70871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Typical acrochordon (skin tag)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 294px; height: 246px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Beth G Goldstein, MD, and Adam O Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22638=[""].join("\n");
var outline_f22_6_22638=null;
var title_f22_6_22639="Normal water balance";
var content_f22_6_22639=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F75632&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F75632&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 489px\">",
"   <div class=\"ttl\">",
"    Normal water balance",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 469px; height: 203px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical daily water balance in a normal human, assuming a low rate of sweat production. When exercise and/or hot weather stimulates sweat production, water losses from the skin can increase markedly, occasionally exceeding 5 L/day. In this setting, the ensuing rise in plasma osmolality stimulates thirst, resulting in an appropriate increase in water intake.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_6_22639=[""].join("\n");
var outline_f22_6_22639=null;
